Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionATP-dependent activity, acting on DNA

BPTF ATRX RSF1 CHD1 ZRANB3 TOP2B

5.52e-06127706GO:0008094
GeneOntologyMolecularFunctionATP-dependent chromatin remodeler activity

ATRX RSF1 CHD1 ZRANB3

8.38e-0637704GO:0140658
GeneOntologyMolecularFunctionchromatin binding

TCF4 SAFB PSIP1 ATRX MBD1 CHD1 MORC2 NKAPL NIPBL HNRNPC TOP2B HDGFL3

8.95e-067397012GO:0003682
GeneOntologyMolecularFunctioncatalytic activity, acting on DNA

BPTF ATRX RSF1 CHD1 NIPBL ZRANB3 TOP2B

3.66e-05262707GO:0140097
GeneOntologyMolecularFunctionhistone binding

BPTF ATRX RSF1 CHD1 MORC2 USP16 DEK

3.94e-05265707GO:0042393
GeneOntologyMolecularFunctionchromo shadow domain binding

ATRX NIPBL

1.80e-046702GO:0070087
GeneOntologyMolecularFunctioninositol 1,4,5 trisphosphate binding

TRPC4 ITPR1

1.07e-0314702GO:0070679
GeneOntologyMolecularFunctionstructural constituent of cytoskeleton

CYLC1 SPTBN1 EPB41L3 ERBIN

1.13e-03130704GO:0005200
GeneOntologyMolecularFunction1-phosphatidylinositol binding

ZFYVE16 EEA1

1.59e-0317702GO:0005545
GeneOntologyBiologicalProcessprotein-DNA complex organization

BPTF NRDE2 TCF4 SAFB PSIP1 ATRX MBD1 RSF1 CHD1 LSM11 MORC2 USP16 DEK NIPBL HNRNPC ZRANB3 HDGFL3 IWS1

3.06e-099996918GO:0071824
GeneOntologyBiologicalProcesschromatin organization

BPTF NRDE2 SAFB PSIP1 ATRX MBD1 RSF1 CHD1 LSM11 MORC2 USP16 DEK NIPBL HNRNPC ZRANB3 HDGFL3 IWS1

4.27e-098966917GO:0006325
GeneOntologyBiologicalProcesschromatin remodeling

BPTF NRDE2 PSIP1 ATRX MBD1 RSF1 CHD1 MORC2 USP16 DEK NIPBL HNRNPC ZRANB3 HDGFL3 IWS1

1.74e-087416915GO:0006338
GeneOntologyBiologicalProcessmRNA processing

SRRT NRDE2 CWF19L2 SAFB PSIP1 SFSWAP ZRANB2 LSM11 CPSF2 HNRNPC IWS1

2.01e-065516911GO:0006397
GeneOntologyBiologicalProcessmRNA metabolic process

SRRT NRDE2 CWF19L2 SAFB TUT4 PSIP1 SFSWAP ZRANB2 LSM11 CPSF2 AP3B1 HNRNPC IWS1

9.32e-069176913GO:0016071
GeneOntologyBiologicalProcesshistone mRNA metabolic process

TUT4 LSM11 CPSF2

6.90e-0524693GO:0008334
GeneOntologyBiologicalProcessmRNA 3'-end processing by stem-loop binding and cleavage

LSM11 CPSF2

1.64e-046692GO:0006398
GeneOntologyBiologicalProcessmitotic sister chromatid cohesion

ATRX NIPBL ESCO1

2.36e-0436693GO:0007064
GeneOntologyCellularComponentheterochromatin

PSIP1 ATRX MBD1 MORC2 TOP2B

2.10e-05101695GO:0000792
GeneOntologyCellularComponentchromatin

BPTF TCF4 PSIP1 ATRX MBD1 RSF1 ANKRD11 CHD1 MORC2 DEK NIPBL ESCO1 HNRNPC TOP2B

2.89e-0414806914GO:0000785
HumanPhenoTriangular nasal tip

TCF4 ATRX

1.46e-052202HP:0000451
HumanPhenoAbnormality of the philtrum

BPTF TCF4 ATRX PCLO SPTBN1 ANKRD11 DYNC2I1 AP3B1 NIPBL HNRNPC ITPR1

2.25e-057262011HP:0000288
HumanPhenoAbnormal eyelid morphology

BPTF TCF4 DMXL2 ATRX PCLO SPTBN1 ANKRD11 DYNC2I1 CHD1 LSM11 AP3B1 NIPBL HNRNPC ITPR1

9.59e-0514082014HP:0000492
HumanPhenoAbnormality of the palpebral fissures

BPTF TCF4 DMXL2 ATRX PCLO SPTBN1 ANKRD11 CHD1 AP3B1 HNRNPC ITPR1

1.42e-048802011HP:0008050
HumanPhenoUpslanted palpebral fissure

BPTF TCF4 ATRX SPTBN1 ANKRD11 AP3B1 ITPR1

1.77e-04333207HP:0000582
HumanPhenoBroad eyebrow

BPTF SPTBN1 CHD1

1.77e-0429203HP:0011229
HumanPhenoSlanting of the palpebral fissure

BPTF TCF4 DMXL2 ATRX SPTBN1 ANKRD11 CHD1 AP3B1 HNRNPC ITPR1

1.81e-047392010HP:0200006
HumanPhenoThin upper lip vermilion

BPTF ATRX SPTBN1 ANKRD11 AP3B1 NIPBL HNRNPC

1.98e-04339207HP:0000219
HumanPhenoThin lips

BPTF ATRX SPTBN1 ANKRD11 AP3B1 NIPBL HNRNPC

1.98e-04339207HP:0000213
DomainZnf_FYVE_PHD

BPTF ATRX ZFYVE16 PCLO RSF1 EEA1

1.44e-05147676IPR011011
DomainWHIM1

BPTF RSF1

1.26e-045672PF15612
DomainWHIM1_dom

BPTF RSF1

1.26e-045672IPR028942
DomainDDT

BPTF RSF1

1.88e-046672PS50827
DomainSNF2_N

ATRX CHD1 ZRANB3

2.03e-0432673IPR000330
DomainSNF2_N

ATRX CHD1 ZRANB3

2.03e-0432673PF00176
Domain-

BPTF ATRX ZFYVE16 PCLO RSF1 EEA1 USP16

1.11e-034496773.30.40.10
DomainZnf_RING/FYVE/PHD

BPTF ATRX ZFYVE16 PCLO RSF1 EEA1 USP16

1.26e-03459677IPR013083
DomainHATPase_c

MORC2 TOP2B

1.87e-0318672SM00387
DomainHATPase_c

MORC2 TOP2B

2.08e-0319672PF02518
DomainPDZ

MAST4 SIPA1L1 PCLO ERBIN

2.12e-03151674PS50106
DomainPDZ

MAST4 SIPA1L1 PCLO ERBIN

2.17e-03152674IPR001478
Domain-

MORC2 TOP2B

2.31e-03206723.30.565.10
DomainPWWP

PSIP1 HDGFL3

2.31e-0320672SM00293
DomainHATPase_C

MORC2 TOP2B

2.55e-0321672IPR003594
Domainzf-RanBP

ZRANB2 ZRANB3

2.80e-0322672PF00641
DomainSAP

SAFB DEK

2.80e-0322672PF02037
DomainActinin_actin-bd_CS

SPTBN1 UTRN

3.06e-0323672IPR001589
DomainPWWP

PSIP1 HDGFL3

3.06e-0323672PF00855
DomainZnF_RBZ

ZRANB2 ZRANB3

3.06e-0323672SM00547
DomainPWWP_dom

PSIP1 HDGFL3

3.06e-0323672IPR000313
DomainSAP

SAFB DEK

3.06e-0323672SM00513
DomainSpectrin

SPTBN1 UTRN

3.06e-0323672PF00435
DomainZF_RANBP2_2

ZRANB2 ZRANB3

3.06e-0323672PS50199
DomainACTININ_2

SPTBN1 UTRN

3.06e-0323672PS00020
DomainACTININ_1

SPTBN1 UTRN

3.06e-0323672PS00019
DomainPWWP

PSIP1 HDGFL3

3.33e-0324672PS50812
DomainZF_RANBP2_1

ZRANB2 ZRANB3

3.33e-0324672PS01358
DomainSAP

SAFB DEK

3.61e-0325672PS50800
DomainZnf_RanBP2

ZRANB2 ZRANB3

3.61e-0325672IPR001876
DomainSAP_dom

SAFB DEK

3.61e-0325672IPR003034
DomainZF_PHD_2

BPTF ATRX RSF1

4.83e-0395673PS50016
DomainFYVE

ZFYVE16 EEA1

4.84e-0329672PF01363
DomainFYVE

ZFYVE16 EEA1

4.84e-0329672SM00064
DomainSpectrin_repeat

SPTBN1 UTRN

4.84e-0329672IPR002017
DomainZF_PHD_1

BPTF ATRX RSF1

4.97e-0396673PS01359
DomainSpectrin/alpha-actinin

SPTBN1 UTRN

5.87e-0332672IPR018159
DomainSPEC

SPTBN1 UTRN

5.87e-0332672SM00150
DomainZnf_FYVE-rel

ZFYVE16 EEA1

6.60e-0334672IPR017455
DomainHelicase_C

ATRX CHD1 ZRANB3

6.71e-03107673PF00271
DomainHELICc

ATRX CHD1 ZRANB3

6.71e-03107673SM00490
DomainHomeodomain-like

PKNOX2 TCF4 MIS18BP1 TIGD2 DEK

6.76e-03332675IPR009057
DomainHelicase_C

ATRX CHD1 ZRANB3

6.89e-03108673IPR001650
DomainHELICASE_CTER

ATRX CHD1 ZRANB3

7.07e-03109673PS51194
DomainHELICASE_ATP_BIND_1

ATRX CHD1 ZRANB3

7.07e-03109673PS51192
DomainDEXDc

ATRX CHD1 ZRANB3

7.07e-03109673SM00487
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

SRRT BPTF SEC16B SAFB PSIP1 SFSWAP ATRX SIPA1L1 SPTBN1 ZRANB2 CAST EIF5B CPSF2 MORC2 USP16 ERBIN NIPBL HNRNPC TOP2B IWS1

3.98e-17774702015302935
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

SRRT BPTF NRDE2 CWF19L2 DMXL2 SAFB PSIP1 SFSWAP P4HA1 SPTBN1 STAU2 KCTD3 ZRANB2 EIF5B CPSF2 EPB41L3 NKAPL DEK NIPBL HNRNPC TOP2B IWS1

1.18e-161082702238697112
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

MRPS31 FAM133B SRRT NRDE2 SFSWAP ATRX P4HA1 SIPA1L1 MBD1 STAU2 KCTD3 ZRANB2 ANKRD11 EIF5B CHD1 LSM11 CPSF2 MORC2 AP3B1 UTRN ERBIN NIPBL IWS1

8.25e-151497702331527615
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

SRRT BPTF CWF19L2 SAFB PSIP1 SFSWAP ATRX STAU2 RSF1 CAST ANKRD11 EIF5B CHD1 EPB41L3 DEK NIPBL HNRNPC TOP2B HDGFL3

3.02e-14954701936373674
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

MRPS31 GPALPP1 CYLC1 FAM133B BPTF SAFB PSIP1 ATRX TNN PCLO SPTBN1 RSF1 EIF5B EEA1 EPB41L3 ERBIN NIPBL HNRNPC TOP2B

4.09e-111442701935575683
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

GPALPP1 SAFB PSIP1 ATRX ZFYVE16 STAU2 RSF1 CAST EIF5B CHD1 EPB41L3 USP16 UTRN ERBIN NIPBL TOP2B

4.12e-11934701633916271
Pubmed

A bead-based approach for large-scale identification of in vitro kinase substrates.

SRRT SAFB PSIP1 RSF1 ZRANB2 EIF5B DEK HNRNPC IWS1

4.45e-1116370922113938
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

MRPS31 DMXL2 PSIP1 ATRX P4HA1 SPTBN1 STAU2 ZRANB2 ANKRD11 EIF5B CHD1 CRYBG3 EPB41L3 AP3B1 USP16 DEK ERBIN TOP2B ITPR1

6.89e-111487701933957083
Pubmed

Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

GPALPP1 SRRT SAFB ATRX SIPA1L1 SPTBN1 STAU2 EIF5B MORC2 TOP2B ITPR1 IWS1

1.91e-10475701231040226
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

FSIP2 BPTF MIS18BP1 PSIP1 ATRX RSF1 CHD1 MORC2 DEK NIPBL TOP2B HDGFL3 IWS1

2.39e-10608701336089195
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

SRRT BPTF SAFB MIS18BP1 PSIP1 ATRX RSF1 EIF5B CHD1 CPSF2 MORC2 DEK NIPBL TOP2B IWS1

1.36e-091014701532416067
Pubmed

SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.

FAM133B BPTF SAFB SFSWAP RSF1 ZRANB2 CPSF2 TOP2B IWS1

2.04e-0925170931076518
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

MRPS31 SRRT SAFB PSIP1 ATRX PCLO SPTBN1 ZRANB2 EIF5B CHD1 EEA1 EPB41L3 AP3B1 DEK NIPBL HNRNPC TOP2B

2.36e-091425701730948266
Pubmed

Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer.

SRRT SAFB ATRX RSF1 ZRANB2 HNRNPC TOP2B IWS1

4.45e-0918870829721183
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

SRRT BPTF SAFB TIGD2 PSIP1 SFSWAP ATRX MBD1 ANKRD11 CPSF2 DEK NIPBL ESCO1 HNRNPC TOP2B IWS1

4.59e-091294701630804502
Pubmed

Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.

BPTF PSIP1 ATRX RSF1 EIF5B CHD1 AP3B1 DEK NIPBL TOP2B HDGFL3

9.46e-09533701130554943
Pubmed

Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.

GPALPP1 SRRT SAFB PSIP1 SFSWAP PCLO SPTBN1 RSF1 ZRANB2 NIPBL

1.38e-08425701024999758
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

CEP350 SRRT BPTF SAFB PSIP1 EIF5B CHD1 EEA1 CPSF2 DEK UTRN NIPBL HNRNPC TOP2B

1.40e-081024701424711643
Pubmed

RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.

MRPS31 SRRT SAFB PSIP1 SFSWAP P4HA1 ZRANB2 EIF5B CPSF2 DEK HNRNPC TOP2B

1.81e-08713701229802200
Pubmed

Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.

SRRT BPTF SAFB ATRX P4HA1 SPTBN1 CAST CPSF2 NIPBL

2.30e-0833270932786267
Pubmed

Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.

BPTF PSIP1 ATRX RSF1 ZRANB2 CHD1 USP16 DEK TOP2B IWS1

3.48e-08469701027634302
Pubmed

A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.

BPTF SAFB PSIP1 ZFYVE16 CAST CHD1 CRYBG3 CPSF2 ERBIN HNRNPC

3.70e-08472701038943005
Pubmed

BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.

MRPS31 GPALPP1 FAM133B SAFB P4HA1 STAU2 EIF5B CHD1 CPSF2 AP3B1 USP16 DEK NIPBL HNRNPC TOP2B

4.49e-081318701530463901
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

MRPS31 FAM133B SRRT SAFB TUT4 PSIP1 SPTBN1 STAU2 ZRANB2 EIF5B DEK HNRNPC

6.97e-08807701222681889
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

CEP350 SRRT NRDE2 SEC16B PSIP1 SFSWAP P4HA1 SPTBN1 STAU2 EEA1 CPSF2 MORC2 AP3B1 DEK HNRNPC

7.51e-081371701536244648
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

CEP350 FSIP2 SRRT MAST4 SIPA1L1 SPTBN1 MBD1 ANKRD11 CRYBG3 EPB41L3 UTRN ERBIN

1.40e-07861701236931259
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

CEP350 ZFYVE16 P4HA1 SPTBN1 KCTD3 CRYBG3 CPSF2 AP3B1 DEK UTRN ERBIN ITPR1 IWS1

1.53e-071049701327880917
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

CEP350 NRDE2 TUT4 STAU2 CAST EIF5B MORC2 EPB41L3 AP3B1 USP16 TOP2B

2.09e-07724701136232890
Pubmed

Interactomes of Glycogen Synthase Kinase-3 Isoforms.

CEP350 MAST4 SIPA1L1 STAU2 CRYBG3 UTRN ERBIN

2.23e-0720970736779422
Pubmed

Phosphoproteome analysis of the human mitotic spindle.

CEP350 MIS18BP1 NUF2 MORC2 NIPBL TOP2B IWS1

2.30e-0721070716565220
Pubmed

Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.

CWF19L2 MIS18BP1 ATRX CHD1 MORC2 AP3B1 NIPBL

3.35e-0722270737071664
Pubmed

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.

SRRT SAFB PSIP1 SFSWAP SPTBN1 CPSF2 DEK HNRNPC TOP2B IWS1

3.66e-07605701028977666
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

SRRT SAFB MIS18BP1 SPTBN1 RSF1 EIF5B CHD1 EPB41L3 USP16 UTRN ERBIN NIPBL HNRNPC TOP2B

4.28e-071353701429467282
Pubmed

Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.

MIS18BP1 PSIP1 RSF1 CHD1 DEK NIPBL TOP2B ITPR1

4.28e-0734070829478914
Pubmed

Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.

CEP350 GPALPP1 MIS18BP1 ZFYVE16 RSF1 MORC2 EPB41L3 UTRN ERBIN IWS1

6.55e-07645701025281560
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

MRPS31 SRRT PSIP1 SPTBN1 ZRANB2 CAST EIF5B CHD1 AP3B1 DEK NIPBL HNRNPC TOP2B IWS1

7.30e-071415701428515276
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

SRRT SAFB STAU2 RSF1 EIF5B MORC2 EPB41L3 NIPBL IWS1

7.67e-0750370916964243
Pubmed

The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.

BPTF ATRX RSF1 NIPBL TOP2B

8.76e-078670537253089
Pubmed

mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.

SRRT SAFB SIPA1L1 SPTBN1 CPSF2 EPB41L3 HNRNPC

1.37e-0627470734244482
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

NRDE2 ATRX SIPA1L1 SPTBN1 GRAMD2B CAST CPSF2 AP3B1 UTRN ERBIN ZRANB3 ITPR1

1.59e-061084701211544199
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

MRPS31 DMXL2 SAFB TUT4 SIPA1L1 PCLO SPTBN1 STAU2 CRYBG3 EPB41L3 ERBIN ITPR1

2.65e-061139701236417873
Pubmed

Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.

SAFB PSIP1 ATRX P4HA1 RSF1 ZRANB2 EIF5B HNRNPC

2.98e-0644170831239290
Pubmed

Protein 4.1B contributes to the organization of peripheral myelinated axons.

SPTBN1 EPB41L3

3.99e-06270221966409
Pubmed

A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis.

SPTBN1 CHD1 AP3B1 UTRN ERBIN

4.19e-0611870527377895
Pubmed

MYC multimers shield stalled replication forks from RNA polymerase.

MRPS31 SRRT BPTF SAFB SFSWAP ZRANB2 CHD1 DEK ERBIN HNRNPC TOP2B

4.35e-06989701136424410
Pubmed

Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.

SAFB PSIP1 PCLO SPTBN1 EIF5B PCNX1 EEA1 AP3B1 UTRN HNRNPC

4.83e-06807701030575818
Pubmed

Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.

SRRT BPTF EIF5B CHD1 CPSF2 ERBIN TOP2B

5.78e-0634170732971831
Pubmed

Identification of FMRP target mRNAs in the developmental brain: FMRP might coordinate Ras/MAPK, Wnt/β-catenin, and mTOR signaling during corticogenesis.

TCF4 NIPBL ITPR1

6.23e-061870333323119
Pubmed

Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.

SRRT SAFB PSIP1 ATRX SPTBN1 NIPBL HNRNPC TOP2B ITPR1

6.36e-0665270931180492
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

CEP350 GPALPP1 SEC16B DMXL2 EIF5B MORC2 EPB41L3 ESCO1

6.73e-0649370815368895
Pubmed

A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.

CEP350 GPALPP1 SRRT KCTD3 EIF5B LSM11 AP3B1 DEK ERBIN HNRNPC IWS1

6.87e-061038701126673895
Pubmed

ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.

SRRT SAFB SPTBN1 EIF5B DEK ERBIN HNRNPC TOP2B IWS1

7.01e-0666070932780723
Pubmed

Comprehensive identification of phosphorylation sites in postsynaptic density preparations.

PSIP1 ATRX SIPA1L1 PCLO SPTBN1 EPB41L3

7.40e-0623170616452087
Pubmed

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

BPTF TCF4 PSIP1 P4HA1 MBD1 EIF5B CPSF2 MORC2 DEK TOP2B

8.17e-06857701025609649
Pubmed

Transcriptome analysis of mouse stem cells and early embryos.

BPTF NRDE2 STAU2 EIF5B UTRN HNRNPC ITPR1

8.68e-0636370714691545
Pubmed

ATG5 is required for B cell polarization and presentation of particulate antigens.

FAM133B NRDE2 CWF19L2 SAFB SFSWAP ZRANB2 CPSF2 TOP2B ITPR1

1.13e-0570170930196744
Pubmed

Human Antiviral Protein IFIX Suppresses Viral Gene Expression during Herpes Simplex Virus 1 (HSV-1) Infection and Is Counteracted by Virus-induced Proteasomal Degradation.

SAFB ATRX EIF5B CHD1 CPSF2 TOP2B

1.19e-0525170628077445
Pubmed

Role of remodeling and spacing factor 1 in histone H2A ubiquitination-mediated gene silencing.

RSF1 USP16

1.20e-05370228855339
Pubmed

The integrase cofactor LEDGF/p75 associates with Iws1 and Spt6 for postintegration silencing of HIV-1 gene expression in latently infected cells.

PSIP1 IWS1

1.20e-05370225590759
Pubmed

Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase.

PSIP1 HDGFL3

1.20e-05370215371438
Pubmed

WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.

ATRX SPTBN1 EEA1 CPSF2 AP3B1 UTRN HNRNPC

1.47e-0539470727248496
Pubmed

The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.

MRPS31 SRRT BPTF TCF4 PSIP1 PCLO DEK

1.52e-0539670726687479
Pubmed

Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia.

MRPS31 SRRT SPTBN1 ERBIN TOP2B

1.53e-0515470536490346
Pubmed

Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.

FSIP2 SRRT SAFB PSIP1 SFSWAP EEA1 DEK

1.60e-0539970735987950
Pubmed

Insights into the ubiquitin-proteasome system of human embryonic stem cells.

SFSWAP ANKRD11 EIF5B CPSF2 EPB41L3 DEK

1.75e-0526970629511261
Pubmed

Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.

SPTBN1 ANKRD11 NIPBL ESCO1 HNRNPC TOP2B

1.87e-0527270631010829
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

ATRX SPTBN1 NUF2 CPSF2 EPB41L3 AP3B1 NIPBL HNRNPC

2.22e-0558270820467437
Pubmed

The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.

GPALPP1 FAM133B CPSF2 MORC2 ESCO1 ZRANB3

2.24e-0528170624163370
Pubmed

Alternative splice variants of hTrp4 differentially interact with the C-terminal portion of the inositol 1,4,5-trisphosphate receptors.

TRPC4 ITPR1

2.39e-05470211163362
Pubmed

Membrane localization of the U2 domain of Protein 4.1B is necessary and sufficient for meningioma growth suppression.

SPTBN1 EPB41L3

2.39e-05470215688033
Pubmed

DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation.

SRRT SAFB CPSF2 HNRNPC

3.23e-058970422446626
Pubmed

Network organization of the huntingtin proteomic interactome in mammalian brain.

SIPA1L1 PCLO SPTBN1 ZRANB2 CHD1 EPB41L3 HNRNPC ITPR1

3.52e-0562170822794259
Pubmed

Multiple cellular proteins interact with LEDGF/p75 through a conserved unstructured consensus motif.

PSIP1 IWS1

3.98e-05570226245978
Pubmed

Disruption of 14-3-3 binding does not impair Protein 4.1B growth suppression.

SPTBN1 EPB41L3

3.98e-05570215116094
Pubmed

TNRC6 proteins modulate hepatitis C virus replication by spatially regulating the binding of miR-122/Ago2 complexes to viral RNA.

FAM133B PSIP1 EIF5B DEK HNRNPC TOP2B

4.39e-0531770630997501
Pubmed

Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.

SRRT PSIP1 SPTBN1 ZRANB2 EPB41L3 DEK HNRNPC TOP2B

4.40e-0564170836057605
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

SRRT NRDE2 DMXL2 ATRX CRYBG3 MORC2 AP3B1 ITPR1

4.86e-0565070838777146
Pubmed

Large-scale mapping of human protein-protein interactions by mass spectrometry.

SRRT NRDE2 SFSWAP ATRX ZRANB2 CHD1 NUF2 CPSF2 EPB41L3 AP3B1 HNRNPC

4.88e-051284701117353931
Pubmed

Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.

SRRT SAFB PSIP1 RSF1 EEA1 AP3B1 HNRNPC IWS1

5.02e-0565370833742100
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

BPTF SPTBN1 RSF1 EIF5B CHD1 EPB41L3 UTRN NIPBL

5.02e-0565370822586326
Pubmed

A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation.

SPTBN1 RSF1 CHD1

5.32e-053670329089422
Pubmed

Oct4 links multiple epigenetic pathways to the pluripotency network.

BPTF TUT4 P4HA1 CPSF2 TOP2B

5.74e-0520370522083510
Pubmed

Aberrant trafficking of the high-affinity choline transporter in AP-3-deficient mice.

EEA1 AP3B1

5.96e-05670218554297
Pubmed

Genetic evidence supporting caveolae microdomain regulation of calcium entry in endothelial cells.

TRPC4 ITPR1

5.96e-05670217416589
Pubmed

Charting the landscape of tandem BRCT domain-mediated protein interactions.

CEP350 SAFB MBD1 EIF5B CPSF2 NKAPL DEK HNRNPC

6.00e-0567070822990118
Pubmed

Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production.

SAFB SPTBN1 CPSF2 NIPBL HNRNPC

6.15e-0520670522174317
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

MRPS31 ATRX SIPA1L1 KCTD3 ZRANB2 EIF5B DYNC2I1 NUF2 RPGR EEA1 AP3B1

6.30e-051321701127173435
Pubmed

Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.

MRPS31 PCLO STAU2 ZRANB2 EIF5B CHD1 EPB41L3

6.35e-0549670731343991
Pubmed

Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.

DMXL2 PSIP1 PCLO EIF5B EPB41L3 AP3B1 HNRNPC

6.51e-0549870736634849
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

GPALPP1 BPTF SAFB PSIP1 ZRANB2 EIF5B MORC2 DEK NIPBL TOP2B

6.98e-051103701034189442
Pubmed

Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.

SFSWAP EPB41L3 NKAPL UTRN ERBIN

7.52e-0521570535973513
Pubmed

Affinity switching of the LEDGF/p75 IBD interactome is governed by kinase-dependent phosphorylation.

PSIP1 IWS1

8.33e-05770229997176
Pubmed

CHD1 associates with NCoR and histone deacetylase as well as with RNA splicing proteins.

SAFB CHD1

8.33e-05770212890497
Pubmed

Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.

NRDE2 IL31RA ATRX EIF5B CHD1 ANKRD36C NKAPL DEK UTRN

8.61e-0591070936736316
Pubmed

N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.

BPTF SAFB SPTBN1 EEA1 UTRN NIPBL

8.86e-0536070633111431
Pubmed

Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.

MRPS31 SRRT SAFB PSIP1 STAU2 CPSF2 HNRNPC TOP2B

9.34e-0571470828302793
Pubmed

TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.

SRRT SFSWAP P4HA1 SIPA1L1 SPTBN1 ANKRD11 CPSF2 EPB41L3 HNRNPC

9.51e-0592270927609421
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

MRPS31 P4HA1 SPTBN1 STAU2 ZRANB2 CAST EIF5B EEA1 AP3B1 HNRNPC

9.78e-051149701035446349
Pubmed

Interactome and Proteome Dynamics Uncover Immune Modulatory Associations of the Pathogen Sensing Factor cGAS.

MRPS31 MBD1 STAU2 CHD1 AP3B1

9.92e-0522870530471916
Pubmed

Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.

MRPS31 TUT4 SFSWAP STAU2 ZRANB2 EIF5B CPSF2 HNRNPC

1.02e-0472370834133714
InteractionMECP2 interactions

SRRT BPTF NRDE2 CWF19L2 DMXL2 SAFB PSIP1 SFSWAP ATRX P4HA1 SPTBN1 STAU2 KCTD3 ZRANB2 EIF5B CPSF2 EPB41L3 NKAPL DEK NIPBL HNRNPC TOP2B IWS1

2.68e-1112877023int:MECP2
InteractionRAD18 interactions

FAM133B BPTF SAFB SFSWAP SPTBN1 RSF1 ZRANB2 CHD1 CPSF2 AP3B1 UTRN ERBIN TOP2B IWS1

4.73e-104577014int:RAD18
InteractionCENPA interactions

SRRT BPTF MIS18BP1 PSIP1 ATRX MBD1 RSF1 ANKRD11 CHD1 MORC2 DEK NIPBL TOP2B

5.07e-103777013int:CENPA
InteractionSMC5 interactions

SRRT BPTF CWF19L2 SAFB PSIP1 SFSWAP ATRX STAU2 RSF1 CAST ANKRD11 EIF5B CHD1 EPB41L3 DEK NIPBL HNRNPC TOP2B HDGFL3

7.97e-1010007019int:SMC5
InteractionKIF20A interactions

SAFB MIS18BP1 PSIP1 SFSWAP P4HA1 PCLO SPTBN1 MBD1 ZRANB2 CHD1 CRYBG3 CPSF2 MORC2 DEK UTRN ERBIN HNRNPC TOP2B ITPR1

1.85e-0910527019int:KIF20A
InteractionCSNK2A1 interactions

MRPS31 SRRT SAFB PSIP1 ATRX P4HA1 SPTBN1 RSF1 ZRANB2 ANKRD11 EIF5B ANKRD36C MORC2 EPB41L3 DEK HNRNPC IWS1

1.98e-089567017int:CSNK2A1
InteractionNUP43 interactions

GPALPP1 FSIP2 SRRT BPTF SAFB MIS18BP1 PSIP1 RSF1 ANKRD11 CHD1 MORC2 NIPBL TOP2B IWS1

2.57e-086257014int:NUP43
InteractionHDAC4 interactions

CCDC125 GPALPP1 SRRT ATRX SIPA1L1 SPTBN1 STAU2 KCTD3 ANKRD11 EIF5B MORC2 AP3B1 TOP2B ITPR1 IWS1

3.05e-087447015int:HDAC4
InteractionZNF330 interactions

CWF19L2 PSIP1 RSF1 ZRANB2 ANKRD11 CHD1 MORC2 DEK NIPBL HNRNPC TOP2B IWS1

3.97e-084467012int:ZNF330
InteractionH2BC8 interactions

GPALPP1 BPTF MIS18BP1 PSIP1 ATRX RSF1 ZRANB2 CHD1 MORC2 DEK NIPBL TOP2B IWS1

7.92e-085767013int:H2BC8
InteractionH2BC21 interactions

CYLC1 BPTF CWF19L2 PSIP1 ATRX TNN PCLO RSF1 EPB41L3 DEK NIPBL ESCO1 TOP2B IWS1

9.73e-086967014int:H2BC21
InteractionH2BC12 interactions

CEP350 CYLC1 ATRX TNN PCLO ANKRD11 EIF5B USP16 TOP2B IWS1

1.60e-073227010int:H2BC12
InteractionNAA40 interactions

GPALPP1 SAFB PSIP1 ATRX ZFYVE16 STAU2 RSF1 CAST EIF5B CHD1 EPB41L3 USP16 UTRN ERBIN NIPBL TOP2B

1.76e-079787016int:NAA40
InteractionCBX3 interactions

SRRT CWF19L2 MIS18BP1 PSIP1 ATRX RSF1 ZRANB2 EIF5B CHD1 MORC2 DEK NIPBL TOP2B

2.96e-076467013int:CBX3
InteractionOBSL1 interactions

MRPS31 SRRT SAFB PSIP1 PCLO STAU2 ZRANB2 EIF5B CHD1 CPSF2 DEK UTRN NIPBL HNRNPC TOP2B

3.71e-079027015int:OBSL1
InteractionPOLR1G interactions

BPTF CWF19L2 TRPC4 RSF1 ZRANB2 ANKRD11 CHD1 MORC2 NIPBL TOP2B IWS1

9.13e-074897011int:POLR1G
InteractionBRD3 interactions

BPTF PSIP1 SFSWAP RSF1 EIF5B CHD1 EPB41L3 DEK NIPBL TOP2B HDGFL3

1.01e-064947011int:BRD3
InteractionH3C3 interactions

FSIP2 BPTF MIS18BP1 ATRX RSF1 CHD1 MORC2 DEK NIPBL TOP2B IWS1

1.03e-064957011int:H3C3
InteractionCIT interactions

BPTF ZNF142 SAFB PSIP1 P4HA1 PCLO SPTBN1 RSF1 EIF5B CHD1 NUF2 CPSF2 NKAPL DEK NIPBL HNRNPC TOP2B IWS1

1.52e-0614507018int:CIT
InteractionH3-3A interactions

BPTF PSIP1 ATRX RSF1 DYNC2I1 CHD1 MORC2 DEK NIPBL HNRNPC TOP2B HDGFL3 IWS1

1.56e-067497013int:H3-3A
InteractionPPIA interactions

GPALPP1 BPTF TCF4 SAFB PSIP1 ZFYVE16 CAST CHD1 CRYBG3 ANKRD36C CPSF2 USP16 ERBIN HNRNPC

1.82e-068887014int:PPIA
InteractionAPEX1 interactions

BPTF CWF19L2 SAFB TUT4 PSIP1 SPTBN1 MBD1 RSF1 ANKRD11 RPGR MORC2 DEK NIPBL HNRNPC TOP2B IWS1

5.53e-0612717016int:APEX1
InteractionDDX23 interactions

GPALPP1 CWF19L2 SAFB SFSWAP ZRANB2 ANKRD11 CHD1 MORC2 TOP2B IWS1

5.91e-064807010int:DDX23
InteractionHMGB1 interactions

SRRT SAFB ATRX RSF1 ZRANB2 EIF5B DYNC2I1 HNRNPC TOP2B IWS1

6.59e-064867010int:HMGB1
InteractionDHX8 interactions

GPALPP1 CWF19L2 SAFB SFSWAP ZRANB2 CHD1 MORC2 HNRNPC

7.65e-06292708int:DHX8
InteractionH3C1 interactions

BPTF PSIP1 ATRX RSF1 ZRANB2 CAST CHD1 MORC2 DEK NIPBL ESCO1 TOP2B HDGFL3

1.16e-059017013int:H3C1
InteractionTERF2IP interactions

BPTF CWF19L2 PSIP1 SFSWAP RSF1 ZRANB2 ANKRD11 CHD1 NIPBL HDGFL3

1.99e-055527010int:TERF2IP
InteractionH2BC9 interactions

CEP350 CYLC1 FSIP2 BPTF PSIP1 ATRX TNN PCLO DEK

2.31e-05446709int:H2BC9
InteractionSFN interactions

CCDC125 CEP350 MAST4 SIPA1L1 SPTBN1 ZRANB2 EIF5B CRYBG3 EEA1 DEK ERBIN

2.47e-056927011int:SFN
InteractionPRC1 interactions

SRRT SAFB PSIP1 ATRX P4HA1 SPTBN1 RSF1 EIF5B CHD1 NKAPL DEK HNRNPC TOP2B

2.62e-059737013int:PRC1
InteractionEFTUD2 interactions

MRPS31 SRRT CWF19L2 PSIP1 SPTBN1 ZRANB2 CAST EIF5B CHD1 CPSF2 AP3B1 DEK NIPBL HNRNPC TOP2B IWS1

2.84e-0514497016int:EFTUD2
InteractionCUL7 interactions

MRPS31 SRRT BPTF SAFB PSIP1 ZRANB2 EIF5B CHD1 EPB41L3 DEK HNRNPC TOP2B

3.09e-058457012int:CUL7
InteractionPOU5F1 interactions

BPTF TCF4 TUT4 PSIP1 P4HA1 EIF5B CHD1 CPSF2 DEK TOP2B

3.21e-055847010int:POU5F1
InteractionPYHIN1 interactions

SAFB ATRX MBD1 RSF1 EIF5B CHD1 CPSF2 TOP2B

3.32e-05358708int:PYHIN1
InteractionSUMO2 interactions

SRRT BPTF SAFB ATRX P4HA1 SPTBN1 CAST CPSF2 NIPBL TOP2B

3.55e-055917010int:SUMO2
InteractionATG16L1 interactions

CEP350 FAM133B NRDE2 CWF19L2 SAFB SFSWAP SIPA1L1 STAU2 ZRANB2 CRYBG3 CPSF2 ERBIN TOP2B ITPR1

3.81e-0511617014int:ATG16L1
InteractionECT2 interactions

SRRT CWF19L2 ZNF142 P4HA1 SPTBN1 MBD1 EIF5B CPSF2 ERBIN HNRNPC TOP2B ITPR1

4.95e-058877012int:ECT2
InteractionDCPS interactions

MIS18BP1 PSIP1 RSF1 CHD1 DEK NIPBL TOP2B ITPR1

6.51e-05394708int:DCPS
InteractionUHRF2 interactions

BPTF TCF4 ATRX RSF1 NIPBL TOP2B

6.85e-05200706int:UHRF2
InteractionNR2C2 interactions

MRPS31 GPALPP1 FAM133B SAFB P4HA1 STAU2 EIF5B CHD1 CPSF2 AP3B1 USP16 DEK NIPBL HNRNPC TOP2B

7.67e-0514037015int:NR2C2
InteractionCHD4 interactions

SRRT BPTF SAFB PSIP1 SFSWAP RSF1 CPSF2 MORC2 DEK HNRNPC TOP2B IWS1

8.46e-059387012int:CHD4
InteractionH2BC13 interactions

CEP350 CYLC1 ATRX TNN PCLO USP16

8.97e-05210706int:H2BC13
InteractionACE2 interactions

SRRT SAFB TUT4 PSIP1 ZFYVE16 SPTBN1 KCTD3 ZRANB2 EEA1 EPB41L3 DEK HNRNPC TOP2B

9.76e-0511067013int:ACE2
InteractionPAF1 interactions

ATRX ZRANB2 CHD1 CPSF2 AP3B1 IWS1

9.95e-05214706int:PAF1
InteractionRNPS1 interactions

GPALPP1 SRRT NRDE2 SFSWAP CPSF2 EPB41L3 DEK HNRNPC

1.10e-04425708int:RNPS1
InteractionRBM14 interactions

SRRT SAFB ATRX P4HA1 STAU2 CPSF2 AP3B1 HNRNPC TOP2B

1.21e-04553709int:RBM14
InteractionSSRP1 interactions

SRRT SAFB ATRX RSF1 ANKRD11 CHD1 NIPBL HNRNPC TOP2B IWS1

1.21e-046857010int:SSRP1
InteractionGLDC interactions

SRRT SAFB SIPA1L1 SPTBN1 CPSF2 EPB41L3 HNRNPC

1.24e-04321707int:GLDC
InteractionEGLN3 interactions

CEP350 TCF4 DMXL2 TUT4 ZFYVE16 KCTD3 ZRANB2 ETAA1 ANKRD11 DYNC2I1 CHD1 NUF2 UTRN ERBIN

1.25e-0412967014int:EGLN3
InteractionHECTD1 interactions

FAM133B SRRT BPTF PSIP1 SFSWAP STAU2 ANKRD11 CPSF2 EPB41L3 DEK UTRN TOP2B

1.33e-049847012int:HECTD1
InteractionSNRNP70 interactions

MRPS31 SRRT SAFB PSIP1 SFSWAP P4HA1 ZRANB2 EIF5B CPSF2 DEK HNRNPC TOP2B

1.33e-049847012int:SNRNP70
InteractionTOP1 interactions

SRRT SAFB P4HA1 RSF1 ZRANB2 CPSF2 NIPBL HNRNPC TOP2B IWS1

1.38e-046967010int:TOP1
InteractionCGAS interactions

MRPS31 MIS18BP1 MBD1 STAU2 CHD1 AP3B1 DEK

1.44e-04329707int:CGAS
InteractionPARP1 interactions

BPTF TCF4 CWF19L2 PSIP1 MBD1 RSF1 ZRANB2 CHD1 EEA1 CPSF2 MORC2 NIPBL TOP2B HDGFL3

1.46e-0413167014int:PARP1
InteractionDNAJC8 interactions

MRPS31 ATRX P4HA1 ANKRD11 CHD1 TOP2B

1.48e-04230706int:DNAJC8
InteractionSLX4 interactions

CEP350 CWF19L2 SAFB MIS18BP1 ATRX CHD1 MORC2 AP3B1 NIPBL

1.56e-04572709int:SLX4
InteractionPAGE2B interactions

SFSWAP ETAA1

1.77e-046702int:PAGE2B
InteractionMEN1 interactions

SRRT BPTF SAFB PSIP1 ATRX EIF5B CHD1 CPSF2 DEK ERBIN HNRNPC TOP2B

2.02e-0410297012int:MEN1
InteractionKIF23 interactions

SRRT ZNF142 SAFB PCLO SPTBN1 STAU2 RSF1 ZRANB2 EIF5B CHD1 HNRNPC TOP2B

2.05e-0410317012int:KIF23
InteractionTPBG interactions

SAFB PSIP1 HNRNPC

2.64e-0436703int:TPBG
InteractionH2BC4 interactions

CEP350 FSIP2 PSIP1 ANKRD11 USP16 TOP2B

2.80e-04259706int:H2BC4
InteractionCEBPA interactions

GPALPP1 BPTF SAFB PSIP1 SPTBN1 ZRANB2 EIF5B CHD1 MORC2 DEK NIPBL HNRNPC TOP2B

3.14e-0412457013int:CEBPA
InteractionLINC02910 interactions

FAM133B SAFB SFSWAP DYNC2I1

3.35e-0495704int:LINC02910
InteractionSNRNP40 interactions

GPALPP1 SRRT CWF19L2 MIS18BP1 SFSWAP RSF1 CHD1 HNRNPC TOP2B

3.47e-04637709int:SNRNP40
InteractionAGR2 interactions

SAFB PSIP1 PCLO SPTBN1 ANKRD11 EIF5B PCNX1 EEA1 AP3B1 UTRN HNRNPC

3.52e-049347011int:AGR2
InteractionWDR76 interactions

SPTBN1 EEA1 CPSF2 AP3B1 UTRN HNRNPC IWS1

3.63e-04383707int:WDR76
InteractionEPB41L3 interactions

TCF4 ATRX SPTBN1 ZRANB2 EPB41L3 AP3B1

3.64e-04272706int:EPB41L3
InteractionYWHAH interactions

CCDC125 CEP350 SRRT MAST4 SFSWAP SIPA1L1 SPTBN1 ANKRD11 CRYBG3 EPB41L3 UTRN ERBIN

3.78e-0411027012int:YWHAH
InteractionKAT6A interactions

MRPS31 CEP350 PSIP1 ATRX RSF1 ZRANB2 MORC2 DEK

3.79e-04510708int:KAT6A
InteractionCACNG5 interactions

ZNF142 MIS18BP1 EPB41L3

3.89e-0441703int:CACNG5
InteractionHDAC1 interactions

SRRT BPTF ATRX ZFYVE16 CHD1 CRYBG3 CPSF2 EPB41L3 UTRN ESCO1 HNRNPC TOP2B

3.97e-0411087012int:HDAC1
InteractionCWC27 interactions

SIPA1L1 EPB41L3 HNRNPC HDGFL3

4.07e-04100704int:CWC27
InteractionTRIM24 interactions

MRPS31 TCF4 TUT4 SPTBN1 MBD1 RSF1 HNRNPC

4.57e-04398707int:TRIM24
InteractionCBX1 interactions

MIS18BP1 PSIP1 ATRX RSF1 NIPBL TOP2B

4.93e-04288706int:CBX1
InteractionELAVL2 interactions

SRRT CWF19L2 SAFB STAU2 HNRNPC

4.96e-04188705int:ELAVL2
InteractionH2BC3 interactions

CYLC1 TNN SPTBN1 CPSF2 USP16 UTRN HNRNPC

5.15e-04406707int:H2BC3
InteractionSUPT5H interactions

CWF19L2 ATRX EIF5B CPSF2 NIPBL HNRNPC IWS1

5.30e-04408707int:SUPT5H
InteractionMIRLET7A1 interactions

SAFB TUT4 LSM11 CPSF2

5.45e-04108704int:MIRLET7A1
InteractionMBD3 interactions

PKNOX2 SRRT BPTF ATRX CPSF2 HNRNPC

5.59e-04295706int:MBD3
InteractionNUPR1 interactions

SRRT SAFB SPTBN1 EIF5B DEK ERBIN HNRNPC TOP2B IWS1

5.74e-04683709int:NUPR1
InteractionCLK2 interactions

GPALPP1 SRRT CPSF2 EPB41L3 HNRNPC

5.86e-04195705int:CLK2
InteractionBIRC3 interactions

MRPS31 SRRT SAFB PSIP1 SPTBN1 ZRANB2 EIF5B CHD1 EEA1 AP3B1 DEK HNRNPC TOP2B

6.07e-0413347013int:BIRC3
InteractionSMC1A interactions

BPTF CWF19L2 ATRX ANKRD11 NUF2 RPGR NIPBL

6.11e-04418707int:SMC1A
InteractionCOIL interactions

CWF19L2 ZRANB2 ANKRD11 CHD1 LSM11 MORC2 NIPBL TOP2B

6.40e-04552708int:COIL
InteractionCDKL5 interactions

GPALPP1 STAU2 ERBIN HDGFL3

6.46e-04113704int:CDKL5
InteractionH3-3B interactions

BPTF ATRX CHD1 IWS1

6.68e-04114704int:H3-3B
InteractionSRSF7 interactions

MRPS31 SRRT SAFB STAU2 ZRANB2 DYNC2I1 HNRNPC

6.74e-04425707int:SRSF7
InteractionHDLBP interactions

SRRT PSIP1 SFSWAP P4HA1 SPTBN1 STAU2 CPSF2 MORC2 AP3B1 USP16

7.07e-048557010int:HDLBP
InteractionMYCN interactions

MRPS31 FAM133B SRRT TCF4 SAFB PSIP1 SFSWAP STAU2 ZRANB2 EIF5B CPSF2 DEK HNRNPC

7.94e-0413737013int:MYCN
InteractionSNCA interactions

SRRT DMXL2 PSIP1 PCLO SPTBN1 EIF5B EPB41L3 AP3B1 HNRNPC

8.04e-04716709int:SNCA
InteractionSUPT16H interactions

SRRT PSIP1 ATRX RSF1 ETAA1 TOP2B IWS1

8.49e-04442707int:SUPT16H
InteractionHECW2 interactions

GPALPP1 FAM133B CPSF2 MORC2 ESCO1 ZRANB3

8.82e-04322706int:HECW2
InteractionPIP4K2A interactions

GPALPP1 ZRANB2 EPB41L3 AP3B1 IWS1

9.28e-04216705int:PIP4K2A
InteractionDLG4 interactions

P4HA1 SIPA1L1 SPTBN1 LSM11 EPB41L3 ERBIN HNRNPC

9.30e-04449707int:DLG4
InteractionEP300 interactions

SRRT TCF4 SAFB PSIP1 MBD1 RSF1 ZRANB2 EEA1 AP3B1 DEK HNRNPC TOP2B IWS1

9.58e-0414017013int:EP300
InteractionNCKAP1 interactions

TCF4 SFSWAP P4HA1 SPTBN1 EPB41L3

9.67e-04218705int:NCKAP1
InteractionNUCKS1 interactions

SRRT PSIP1 ATRX RSF1 TOP2B

1.01e-03220705int:NUCKS1
InteractionH2AX interactions

BPTF PSIP1 ATRX RSF1 DYNC2I1 MORC2 NIPBL HNRNPC

1.02e-03593708int:H2AX
InteractionMAST3 interactions

MRPS31 MAST4 SIPA1L1 KCTD3

1.06e-03129704int:MAST3
InteractionSNW1 interactions

CCDC125 CWF19L2 ATRX SPTBN1 NUF2 CPSF2 AP3B1 NIPBL HNRNPC

1.08e-03747709int:SNW1
Cytoband5q12.3

MAST4 ERBIN

3.45e-04187025q12.3
Cytoband14q24.2

SIPA1L1 PCNX1

6.72e-042570214q24.2
Cytoband1q25.2

CEP350 SEC16B

1.04e-03317021q25.2
CytobandXq21.1

CYLC1 ATRX

1.17e-0333702Xq21.1
CytobandEnsembl 112 genes in cytogenetic band chr1q25

CEP350 SEC16B TNN

2.16e-03167703chr1q25
GeneFamilyPDZ domain containing

MAST4 SIPA1L1 PCLO ERBIN

3.14e-041523941220
GeneFamilyZinc fingers RANBP2-type |RNA binding motif containing

ZRANB2 ZRANB3

9.28e-042139289
GeneFamilyZinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors

ZFYVE16 EEA1

2.03e-033139281
CoexpressionHAMAI_APOPTOSIS_VIA_TRAIL_UP

MRPS31 CEP350 GPALPP1 BPTF TCF4 CWF19L2 TUT4 MIS18BP1 PENK RSF1 CAST ETAA1 EIF5B DYNC2I1 CHD1 NUF2 RPGR EEA1 EPB41L3 AP3B1 DEK NIPBL TOP2B ITPR1 IWS1

1.31e-226567025M18979
CoexpressionMILI_PSEUDOPODIA_HAPTOTAXIS_UP

FAM133B TIGD2 PSIP1 ATRX ZRANB2 ANKRD11 EIF5B USP16 DEK ERBIN NIPBL ESCO1 HDGFL3 IWS1

9.27e-115237014M12707
CoexpressionMILI_PSEUDOPODIA_HAPTOTAXIS_UP

FAM133B TIGD2 PSIP1 ATRX ZRANB2 ANKRD11 EIF5B USP16 DEK ERBIN NIPBL ESCO1 HDGFL3 IWS1

1.22e-105347014MM1054
CoexpressionMENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS

BPTF PSIP1 ATRX RSF1 ANKRD11 DEK TOP2B

4.46e-0990707M39250
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

CEP350 BPTF DMXL2 TUT4 ATRX ZFYVE16 SIPA1L1 STAU2 CHD1 RPGR CRYBG3 AP3B1 DEK NIPBL ITPR1

6.14e-098567015M4500
CoexpressionZHENG_CORD_BLOOD_C7_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_1

MIS18BP1 SPTBN1 ZRANB2 CHD1 ANKRD36C DEK

2.24e-0796706M39216
CoexpressionGSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_UP

FAM133B SIPA1L1 RSF1 CAST CHD1 ERBIN TOP2B

4.24e-07174707M8925
CoexpressionMARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN

TCF4 SFSWAP ATRX MBD1 GRAMD2B EIF5B EPB41L3 USP16 UTRN ERBIN

1.16e-065197010M3395
CoexpressionBUSSLINGER_GASTRIC_IMMUNE_CELLS

CEP350 BPTF TUT4 MIS18BP1 PSIP1 ATRX RSF1 ANKRD11 PCNX1 CHD1 DEK UTRN ERBIN NIPBL TOP2B ITPR1

1.49e-0614927016M40023
CoexpressionMARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN

TCF4 SFSWAP ATRX MBD1 GRAMD2B EIF5B EPB41L3 USP16 UTRN ERBIN

1.74e-065437010MM997
CoexpressionLAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2

CWF19L2 MAST4 SIPA1L1 PCLO ANKRD11 DYNC2I1 EPB41L3

2.10e-06221707M39222
CoexpressionMARKEY_RB1_ACUTE_LOF_UP

MIS18BP1 PSIP1 PENK CPSF2 DEK NIPBL HNRNPC

3.34e-06237707M15606
CoexpressionMARKEY_RB1_ACUTE_LOF_UP

MIS18BP1 PSIP1 PENK CPSF2 DEK NIPBL HNRNPC

3.63e-06240707MM976
CoexpressionTABULA_MURIS_SENIS_MARROW_MATURE_ALPHA_BETA_T_CELL_AGEING

PSIP1 SFSWAP ATRX SIPA1L1 MBD1 RSF1 ZRANB2 EIF5B ERBIN ITPR1

5.04e-066127010MM3804
CoexpressionGSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP

CEP350 BPTF TUT4 SIPA1L1 UTRN IWS1

8.79e-06180706M8239
CoexpressionAIZARANI_LIVER_C20_LSECS_3

TCF4 MAST4 ANKRD11 EIF5B DYNC2I1 RPGR EEA1

1.39e-05295707M39121
CoexpressionGSE14308_TH1_VS_NAIVE_CD4_TCELL_DN

SMTNL1 TUT4 SFSWAP MORC2 ESCO1 HNRNPC

1.60e-05200706M3377
CoexpressionGSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_UP

MAST4 PSIP1 SPTBN1 KCTD3 CRYBG3 MORC2

1.60e-05200706M9883
CoexpressionKINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP

GPALPP1 CWF19L2 SAFB SIPA1L1 TRPC4 STAU2 KCTD3 EIF5B NUF2 CPSF2 DEK HNRNPC ZRANB3

3.23e-0512907013M80
CoexpressionMURARO_PANCREAS_BETA_CELL

DMXL2 MIS18BP1 MAST4 PSIP1 ATRX PCLO MBD1 EPB41L3 AP3B1 UTRN HNRNPC

3.94e-059467011M39169
CoexpressionWANG_LMO4_TARGETS_DN

MRPS31 NRDE2 SPTBN1 MBD1 EIF5B CPSF2 AP3B1

5.05e-05361707M12674
CoexpressionNAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE

FAM133B CWF19L2 ATRX CHD1 USP16 ESCO1 ITPR1

5.23e-05363707M41103
CoexpressionFAN_OVARY_CL9_PUTATIVE_APOPTOTIC_ENDOTHELIAL_CELL

TCF4 MAST4 SPTBN1 CAST ANKRD11 EIF5B DEK

5.41e-05365707M41711
CoexpressionNAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP

CEP350 TCF4 DMXL2 SFSWAP ATRX P4HA1 SPTBN1 MBD1 EIF5B EEA1 ERBIN NIPBL

8.22e-0512157012M41122
CoexpressionGSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP

TCF4 MIS18BP1 NUF2 EEA1 ITPR1

9.84e-05172705M8932
CoexpressionMARSON_BOUND_BY_FOXP3_UNSTIMULATED

MRPS31 TCF4 CWF19L2 MIS18BP1 ETAA1 DYNC2I1 NUF2 EEA1 CPSF2 MORC2 ZRANB3 TOP2B

9.89e-0512397012M1743
CoexpressionLAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS

TCF4 SPTBN1 ANKRD11 UTRN ITPR1

1.13e-04177705M39245
CoexpressionGSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN

TCF4 ATRX RSF1 CHD1 ERBIN

1.19e-04179705M8928
CoexpressionMARSON_BOUND_BY_FOXP3_UNSTIMULATED

MRPS31 TCF4 CWF19L2 MIS18BP1 ETAA1 DYNC2I1 NUF2 EEA1 CPSF2 MORC2 ZRANB3 TOP2B

1.31e-0412777012MM1032
CoexpressionPARENT_MTOR_SIGNALING_UP

CEP350 SRRT TCF4 ZNF142 PSIP1 CAST RPGR AP3B1

1.33e-04567708M16909
CoexpressionLAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED

TCF4 CAST UTRN

1.44e-0438703M39244
CoexpressionDAZARD_RESPONSE_TO_UV_NHEK_DN

CEP350 BPTF TUT4 MAST4 ATRX CHD1

1.52e-04300706M8702
CoexpressionGSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN

ATRX P4HA1 GRAMD2B CRYBG3 ERBIN

1.81e-04196705M7124
CoexpressionGSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP

MAST4 CAST EIF5B NIPBL IWS1

1.90e-04198705M4249
CoexpressionWHITFIELD_CELL_CYCLE_G2_M

MIS18BP1 SPTBN1 NUF2 USP16 ITPR1

1.90e-04198705M2077
CoexpressionGSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP

IL31RA TUT4 GRAMD2B EPB41L3 TOP2B

1.95e-04199705M6443
CoexpressionGSE369_IFNG_KO_VS_WT_LIVER_UP

TUT4 ATRX SPTBN1 MBD1 NIPBL

1.95e-04199705M5970
CoexpressionGSE17721_0.5H_VS_12H_LPS_BMDC_DN

CEP350 TCF4 PENK PCNX1 CPSF2

1.95e-04199705M4069
CoexpressionGSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN

PSIP1 GRAMD2B ANKRD11 AP3B1 ERBIN

1.99e-04200705M5806
CoexpressionGSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP

BPTF ZFYVE16 PCNX1 CHD1 DEK

1.99e-04200705M3251
CoexpressionGSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_UP

SRRT SAFB MBD1 PCNX1 AP3B1

1.99e-04200705M7073
CoexpressionGSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_DN

MRPS31 RPGR CRYBG3 CPSF2 AP3B1

1.99e-04200705M3527
CoexpressionGSE27786_LSK_VS_NEUTROPHIL_UP

FAM133B TUT4 PSIP1 STAU2 IWS1

1.99e-04200705M4760
CoexpressionGSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_DN

CYLC1 NRDE2 ETAA1 EIF5B AP3B1

1.99e-04200705M3973
CoexpressionGSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN

CWF19L2 IL31RA EIF5B UTRN ITPR1

1.99e-04200705M7505
CoexpressionSTARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP

TCF4 SPTBN1 RSF1 ANKRD11 LSM11

2.28e-04206705M2817
CoexpressionSTARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP

TCF4 SPTBN1 RSF1 ANKRD11 LSM11

2.39e-04208705MM581
CoexpressionSCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN

TCF4 SPTBN1 ANKRD11

2.39e-0445703M1369
CoexpressionSCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN

TCF4 SPTBN1 ANKRD11

2.39e-0445703MM576
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN

CEP350 BPTF TUT4 ATRX STAU2 CHD1 RPGR

2.45e-04466707M13522
CoexpressionLAKE_ADULT_KIDNEY_C2_PODOCYTES

CAST ANKRD11 EEA1 UTRN ERBIN

2.61e-04212705M39221
CoexpressionNAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP

SRRT SFSWAP EEA1 EPB41L3 NIPBL

3.03e-04219705M41199
CoexpressionDIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP

MRPS31 PSIP1 ATRX P4HA1 STAU2 KCTD3 CAST AP3B1 DEK ERBIN HNRNPC HDGFL3

3.05e-0413997012M535
CoexpressionTHAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP

MRPS31 CEP350 FAM133B CWF19L2 MIS18BP1 PSIP1 NIPBL TOP2B

3.63e-04658708M40871
CoexpressionZHENG_BOUND_BY_FOXP3

P4HA1 SPTBN1 CAST ANKRD11 UTRN NIPBL TOP2B

3.66e-04498707M1741
CoexpressionZHENG_BOUND_BY_FOXP3

P4HA1 SPTBN1 CAST ANKRD11 UTRN NIPBL TOP2B

4.07e-04507707MM1030
CoexpressionNAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN

CWF19L2 PSIP1 SFSWAP SIPA1L1 CHD1 USP16 ESCO1 HNRNPC

4.51e-04680708M41089
CoexpressionJOHNSTONE_PARVB_TARGETS_3_DN

CEP350 MIS18BP1 PSIP1 CAST NUF2 DEK HNRNPC HDGFL3 IWS1

5.27e-04877709M2241
CoexpressionHALLMARK_UV_RESPONSE_DN

MRPS31 ATRX SIPA1L1 NIPBL

6.05e-04144704M5942
CoexpressionINAMURA_LUNG_CANCER_SCC_SUBTYPES_UP

P4HA1 CPSF2

6.27e-0414702M1256
CoexpressionRODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP

ATRX RSF1 CAST EIF5B NUF2 CPSF2 USP16 NIPBL

6.62e-04721708M10237
CoexpressionGENTILE_UV_LOW_DOSE_DN

SIPA1L1 AP3B1 UTRN

6.76e-0464703M4594
CoexpressionKIM_GERMINAL_CENTER_T_HELPER_UP

STAU2 ANKRD11 CPSF2

6.76e-0464703M1405
CoexpressionBASAKI_YBX1_TARGETS_DN

BPTF DMXL2 MAST4 ATRX P4HA1 RSF1

6.82e-04398706M14877
CoexpressionFEVR_CTNNB1_TARGETS_DN

MIS18BP1 RSF1 ETAA1 NUF2 RPGR AP3B1 DEK

6.96e-04555707M2343
CoexpressionDURCHDEWALD_SKIN_CARCINOGENESIS_DN

CEP350 CAST CRYBG3 EEA1 UTRN

7.21e-04265705M1684
CoexpressionLAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR

TCF4 SPTBN1 CRYBG3 UTRN

7.40e-04152704M39243
CoexpressionAtlasFacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3

FAM133B CWF19L2 SAFB PSIP1 PCLO RSF1 ZRANB2 ETAA1 ANKRD11 EIF5B CHD1 USP16 NIPBL ESCO1 IWS1

1.29e-105326915Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500_K3

CEP350 PKNOX2 BPTF CWF19L2 TUT4 MIS18BP1 PSIP1 ATRX RSF1 ETAA1 EIF5B DYNC2I1 CHD1 RPGR CPSF2 USP16 DEK NIPBL ZRANB3 HDGFL3 IWS1

2.46e-1012576921facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500

CEP350 PKNOX2 BPTF CWF19L2 TUT4 MIS18BP1 PSIP1 ATRX RSF1 ETAA1 EIF5B DYNC2I1 CHD1 RPGR CPSF2 USP16 DEK NIPBL ZRANB3 HDGFL3 IWS1

3.63e-0914596921facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlasFacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1

TCF4 CWF19L2 MIS18BP1 ATRX RSF1 ETAA1 ANKRD11 EIF5B CHD1 DEK NIPBL IWS1

3.30e-084696912Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlasfacebase_RNAseq_e10.5_MandArch_2500_K1

PKNOX2 CWF19L2 TUT4 MIS18BP1 PSIP1 ATRX PENK RSF1 ETAA1 EIF5B DYNC2I1 RPGR USP16 DEK ERBIN NIPBL TOP2B HDGFL3

5.59e-0812416918facebase_RNAseq_e10.5_MandArch_2500_K1
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2

CWF19L2 SAFB TUT4 ATRX RPGR AP3B1 DEK NIPBL TOP2B IWS1

6.23e-083116910Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlasfacebase_RNAseq_e10.5_MaxArch_2500_K3

PKNOX2 CWF19L2 TUT4 MIS18BP1 PSIP1 ATRX STAU2 RSF1 ETAA1 EIF5B DYNC2I1 CHD1 RPGR DEK NIPBL TOP2B HDGFL3

3.62e-0712526917facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlasfacebase_RNAseq_e10.5_MandArch_2500

PKNOX2 CWF19L2 TUT4 MIS18BP1 PSIP1 ATRX PENK RSF1 ETAA1 EIF5B DYNC2I1 RPGR USP16 DEK ERBIN NIPBL TOP2B HDGFL3

6.80e-0714686918facebase_RNAseq_e10.5_MandArch_2500
CoexpressionAtlasFacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1

DMXL2 TUT4 MIS18BP1 MAST4 ATRX DYNC2I1 EEA1 AP3B1 ERBIN NIPBL TOP2B HDGFL3 IWS1

1.16e-067806913Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5

CWF19L2 DMXL2 SAFB ATRX PCLO CHD1 EEA1 AP3B1 DEK NIPBL TOP2B IWS1

1.35e-058316912Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000

PKNOX2 CWF19L2 SAFB TUT4 ATRX PCLO CHD1 RPGR AP3B1 DEK NIPBL TOP2B IWS1

1.53e-059896913Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlasFacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1

MIS18BP1 PCLO RSF1 ANKRD11 EIF5B CPSF2 NIPBL

2.10e-05259697Facebase_RNAseq_e8.5_Floor Plate_1000_K1
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4

BPTF ZNF142 ATRX SIPA1L1 PCLO NUF2 RPGR AP3B1 DEK ZRANB3

2.13e-055956910Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlasFacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500

MIS18BP1 ATRX PCLO DYNC2I1 RPGR AP3B1 UTRN NIPBL IWS1

2.95e-05492699Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500
CoexpressionAtlasFacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5

BPTF ZNF142 ATRX DYNC2I1 NUF2 AP3B1 DEK NIPBL ZRANB3 IWS1

3.41e-056296910Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3

CWF19L2 SAFB ATRX DEK NIPBL IWS1

3.78e-05192696Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlasFacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4

ATRX PCLO DYNC2I1 AP3B1 NIPBL IWS1

3.78e-05192696Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4
CoexpressionAtlasFacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3

TUT4 MIS18BP1 ATRX DYNC2I1 AP3B1 NIPBL IWS1

4.41e-05291697Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_200

MAST4 SFSWAP ATRX UTRN

4.63e-0561694gudmap_developingGonad_e12.5_epididymis_k2_200
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5

CEP350 CWF19L2 SAFB PCLO EIF5B DYNC2I1 CHD1 DEK TOP2B IWS1

4.74e-056546910Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000

CWF19L2 DMXL2 MIS18BP1 MAST4 SFSWAP ATRX SPTBN1 ANKRD11 RPGR UTRN ESCO1

5.26e-058046911gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500

MIS18BP1 MAST4 SFSWAP ATRX SPTBN1 RPGR UTRN ESCO1

5.30e-05409698gudmap_developingGonad_e12.5_ovary_500
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000

PKNOX2 MIS18BP1 MAST4 SFSWAP ATRX SPTBN1 RSF1 ANKRD11 EIF5B UTRN ESCO1

5.38e-058066911gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlasDevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500

MAST4 SFSWAP ATRX SPTBN1

5.95e-0565694gudmap_developingGonad_P2_ovary_500_k2
CoexpressionAtlasDevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000

MAST4 SFSWAP ATRX SPTBN1 ANKRD11 UTRN

6.22e-05210696gudmap_developingGonad_e18.5_ovary_1000_k2
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000

CEP350 CWF19L2 SAFB PSIP1 PCLO ANKRD11 EIF5B DYNC2I1 CHD1 DEK TOP2B IWS1

6.97e-059836912Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlasFacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000

TUT4 MIS18BP1 ATRX PCLO STAU2 DYNC2I1 RPGR AP3B1 DEK NIPBL ZRANB3 IWS1

7.38e-059896912Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2

CEP350 CWF19L2 SAFB PCLO CHD1 DEK IWS1

9.35e-05328697Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2
CoexpressionAtlasDevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000

MAST4 SFSWAP ATRX SPTBN1 ANKRD11 UTRN

1.03e-04230696gudmap_developingGonad_e16.5_ovary_1000_k2
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5

CWF19L2 EIF5B DYNC2I1 CHD1 DEK IWS1

1.08e-04232696Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5
CoexpressionAtlasfacebase_RNAseq_e10.5_NeuroEpith_central_2500_K4

PKNOX2 BPTF CWF19L2 TUT4 MIS18BP1 PSIP1 ATRX RSF1 ETAA1 DYNC2I1 CHD1 DEK NIPBL TOP2B

1.10e-0413706914facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500

MAST4 SFSWAP ATRX ANKRD11 UTRN

1.29e-04150695gudmap_developingGonad_e12.5_epididymis_k5_500
CoexpressionAtlasDevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000

MAST4 SFSWAP ATRX SPTBN1 ANKRD11 UTRN

1.58e-04249696gudmap_developingGonad_P2_epididymis_1000_k3
CoexpressionAtlasDevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_200

MAST4 SFSWAP ATRX SPTBN1 PENK

1.59e-04157695gudmap_developingGonad_P2_epididymis_200
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_200

MIS18BP1 MAST4 SFSWAP ATRX UTRN

1.69e-04159695gudmap_developingGonad_e12.5_epididymis_200
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_100

MAST4 SFSWAP ATRX SPTBN1

1.77e-0486694gudmap_developingGonad_e16.5_epididymis_100
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500

MAST4 SFSWAP ATRX SPTBN1 UTRN

1.79e-04161695gudmap_developingGonad_e12.5_ovary_k3_500
CoexpressionAtlasDevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000

DMXL2 MIS18BP1 MAST4 SFSWAP ATRX SPTBN1 STAU2 RPGR EEA1 ESCO1

1.82e-047706910gudmap_developingGonad_P2_ovary_1000
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500

MAST4 ATRX SPTBN1 ANKRD11 UTRN

1.84e-04162695gudmap_developingGonad_e16.5_epididymis_500_k2
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000

MAST4 SFSWAP ATRX SPTBN1 ANKRD11 UTRN

1.96e-04259696gudmap_developingGonad_e12.5_epididymis_k3_1000
CoexpressionAtlasDevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000

DMXL2 MAST4 SFSWAP ATRX SPTBN1 ANKRD11 RPGR EEA1 UTRN ESCO1

1.98e-047786910gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200

MAST4 SFSWAP ATRX SPTBN1 PENK

2.06e-04166695gudmap_developingGonad_e18.5_epididymis_200
CoexpressionAtlasDevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000

CEP350 TUT4 ATRX PENK CHD1 TOP2B ITPR1

2.13e-04375697gudmap_developingKidney_e15.5_cortic collect duct_1000_k4
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000

ZNF142 MIS18BP1 MAST4 SFSWAP ATRX SPTBN1 PENK ANKRD11 UTRN ESCO1

2.24e-047906910gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlasDevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000

DMXL2 MAST4 SFSWAP ATRX SPTBN1 STAU2 ANKRD11 RPGR UTRN ESCO1

2.35e-047956910gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlasDevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500

DMXL2 MIS18BP1 MAST4 SFSWAP ATRX RPGR ESCO1

2.39e-04382697gudmap_developingGonad_e14.5_ ovary_500
CoexpressionAtlasDevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_500

TUT4 CHD1 EPB41L3 ITPR1

2.50e-0494694gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k4
CoexpressionAtlasDevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000

ZNF142 TUT4 MIS18BP1 MAST4 SFSWAP ATRX SPTBN1 ANKRD11 UTRN ESCO1

2.50e-048016910gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlasDevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500

DMXL2 MAST4 SFSWAP ATRX SPTBN1 RPGR ESCO1

2.58e-04387697gudmap_developingGonad_e18.5_ovary_500
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000

MAST4 SFSWAP ATRX SPTBN1 ANKRD11 UTRN

2.81e-04277696gudmap_developingGonad_e12.5_ovary_k3_1000
CoexpressionAtlasDevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500

MAST4 SFSWAP ATRX SPTBN1

2.82e-0497694gudmap_developingGonad_e18.5_ovary_500_k3
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000

MAST4 SFSWAP ATRX SPTBN1 ANKRD11 UTRN

3.04e-04281696gudmap_developingGonad_e18.5_epididymis_1000_k3
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500

MIS18BP1 MAST4 SFSWAP ATRX ANKRD11 UTRN ESCO1

3.30e-04403697gudmap_developingGonad_e12.5_epididymis_500
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500

MAST4 SFSWAP ATRX SPTBN1 PENK ANKRD11 UTRN

3.45e-04406697gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlasFacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4

TUT4 MIS18BP1 ATRX STAU2 RPGR NIPBL

4.15e-04298696Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4
CoexpressionAtlasFacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2

BPTF ZNF142 ATRX NUF2 RPGR AP3B1 DEK UTRN

4.75e-04564698Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlasDevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500

CEP350 TUT4 ATRX PENK CHD1

4.97e-04201695gudmap_developingKidney_e15.5_500_k3
CoexpressionAtlasFacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3

TUT4 MIS18BP1 ATRX STAU2 DYNC2I1 AP3B1 NIPBL

5.00e-04432697Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3
CoexpressionAtlasFacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4

ATRX NUF2 RPGR AP3B1 UTRN

5.20e-04203695Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_MedNas_2500_K1

PKNOX2 CWF19L2 TUT4 MIS18BP1 PSIP1 ATRX DYNC2I1 CHD1 RPGR DEK NIPBL

5.81e-0410606911facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlasalpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1

CEP350 TUT4 GRAMD2B UTRN TOP2B HDGFL3

7.79e-04336696GSM538413_500
CoexpressionAtlasDevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000

MAST4 SFSWAP ATRX SPTBN1 UTRN

8.28e-04225695gudmap_developingGonad_e14.5_ ovary_1000_k3
CoexpressionAtlasDevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000

DMXL2 MIS18BP1 MAST4 SFSWAP ATRX SPTBN1 RPGR UTRN ESCO1

8.84e-04776699gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_100

MAST4 SFSWAP

9.23e-0414692gudmap_developingGonad_e16.5_epididymis_100_k4
CoexpressionAtlasDevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500

MAST4 SFSWAP ATRX SPTBN1

1.01e-03136694gudmap_developingGonad_P2_epididymis_500_k2
CoexpressionAtlasDevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000

CEP350 BPTF TUT4 ATRX PENK CHD1 EPB41L3 UTRN TOP2B

1.05e-03795699gudmap_developingKidney_e15.5_anlage of loop of Henle_1000
CoexpressionAtlasDevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000

MIS18BP1 MAST4 SFSWAP ATRX SPTBN1 PENK ANKRD11 UTRN ESCO1

1.07e-03797699gudmap_developingGonad_P2_epididymis_1000
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000

MIS18BP1 MAST4 SFSWAP ATRX SPTBN1 PENK ANKRD11 UTRN ESCO1

1.09e-03799699gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500

CWF19L2 PCLO EIF5B DYNC2I1 CHD1 DEK IWS1

1.09e-03493697Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500

CWF19L2 SAFB ATRX PCLO DEK NIPBL IWS1

1.15e-03498697Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlasDevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#1_top-relative-expression-ranked_1000

ATRX PENK EPB41L3 TOP2B

1.18e-03142694gudmap_developingKidney_e15.5_1000_k1
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#2_top-relative-expression-ranked_200

MAST4 SFSWAP ATRX

1.24e-0365693gudmap_developingGonad_e12.5_ovary_k2_200
CoexpressionAtlasFacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000

TUT4 MIS18BP1 ATRX PCLO DYNC2I1 RPGR AP3B1 UTRN NIPBL IWS1

1.25e-039856910Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
CoexpressionAtlasDevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000

TUT4 MIS18BP1 MAST4 SFSWAP ATRX SPTBN1 RPGR UTRN ESCO1

1.25e-03815699gudmap_developingGonad_e11.5_ovary + mesonephros_1000
CoexpressionAtlasDevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#3_top-relative-expression-ranked_1000

MIS18BP1 MAST4 SFSWAP

1.36e-0367693gudmap_developingGonad_e12.5_testes_k3_1000
CoexpressionAtlasDevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000

CEP350 BPTF TUT4 ATRX CHD1 UTRN

1.45e-03379696gudmap_developingKidney_e15.5_1000_k3
CoexpressionAtlasDevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500

DMXL2 MAST4 SFSWAP ATRX SPTBN1 RPGR

1.45e-03379696gudmap_developingGonad_P2_ovary_500
CoexpressionAtlasDevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_200

MAST4 SFSWAP ATRX

1.48e-0369693gudmap_developingGonad_e11.5_ovary + mesonephros_k5_200
CoexpressionAtlasDevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_1000

CEP350 PENK EPB41L3 TOP2B

1.48e-03151694gudmap_developingLowerUrinaryTract_P1_ureter_1000_k4
CoexpressionAtlasDevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000

MAST4 SFSWAP ATRX SPTBN1

1.48e-03151694gudmap_developingGonad_P2_ovary_1000_k5
CoexpressionAtlasDevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_200

MAST4 ATRX

1.54e-0318692gudmap_developingGonad_P2_epididymis_200_k4
CoexpressionAtlasB cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2

TCF4 IL31RA MIS18BP1 NUF2 ZRANB3 ITPR1

1.63e-03388696GSM538352_500
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000

CEP350 RSF1 EPB41L3 AP3B1 UTRN TOP2B

1.83e-03397696gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_200

MAST4 ATRX SPTBN1

1.95e-0376693gudmap_developingGonad_e16.5_epididymis_200_k4
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500

MAST4 SFSWAP ATRX SPTBN1 PENK UTRN

2.00e-03404696gudmap_developingGonad_e18.5_epididymis_500
CoexpressionAtlasDevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000

MAST4 ATRX ANKRD11 UTRN ESCO1

2.01e-03275695gudmap_developingGonad_e14.5_ epididymis_1000_k3
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200

MAST4 SFSWAP ATRX SPTBN1

2.10e-03166694gudmap_developingGonad_e16.5_epididymis_200
CoexpressionAtlasDevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200

MAST4 SFSWAP ATRX SPTBN1

2.14e-03167694gudmap_developingGonad_e14.5_ epididymis_200
CoexpressionAtlasDevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#5_top-relative-expression-ranked_1000

ATRX PENK TOP2B

2.18e-0379693gudmap_developingKidney_e15.5_Peripheral blastema_1000_k5
CoexpressionAtlasDevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000

DMXL2 RPGR EEA1 ESCO1

2.19e-03168694gudmap_developingGonad_P2_ovary_1000_k4
CoexpressionAtlasDevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500

MAST4 SFSWAP ATRX SPTBN1 ANKRD11 UTRN

2.23e-03413696gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlasDevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500

MAST4 SFSWAP ATRX RPGR

2.39e-03172694gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500
CoexpressionAtlasFacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#2

PCLO DEK ZRANB3 IWS1

2.44e-03173694Facebase_RNAseq_e10.5_Maxillary Arch_1000_K2
CoexpressionAtlasfacebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0

MRPS31 PKNOX2 FAM133B MIS18BP1 PSIP1 ZRANB2 ETAA1 CHD1 DEK ZRANB3

2.46e-0310806910facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_100

MAST4 SFSWAP SPTBN1

2.51e-0383693gudmap_developingGonad_e18.5_epididymis_100
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_200

MAST4 ATRX

2.52e-0323692gudmap_developingGonad_e18.5_epididymis_200_k2
CoexpressionAtlasDevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500

SFSWAP SPTBN1 ANKRD11 UTRN

2.54e-03175694gudmap_developingGonad_e14.5_ epididymis_500_k4
CoexpressionAtlasFacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4

TCF4 TUT4 MIS18BP1 ATRX STAU2 DYNC2I1 EPB41L3 NIPBL

2.78e-03744698Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4

CWF19L2 PCLO CHD1 DEK IWS1

2.84e-03298695Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#1_top-relative-expression-ranked_100

MAST4 ATRX

3.22e-0326692gudmap_developingGonad_e12.5_ovary_k1_100
ToppCell(10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition

CEP350 BPTF MIS18BP1 MBD1 RSF1 CAST ANKRD11 EIF5B DYNC2I1 RPGR EEA1 USP16 NIPBL

6.35e-18199701361b1ed2db71b96157b92b7535d1955a4033098da
ToppCell(03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition

CEP350 BPTF ATRX PCLO MBD1 RSF1 ANKRD11 EIF5B EEA1 USP16 DEK UTRN NIPBL

6.35e-181997013c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCelldroplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CEP350 TCF4 TUT4 ATRX SPTBN1 RSF1 ANKRD11 CHD1 UTRN ERBIN NIPBL TOP2B

1.32e-1618470121154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell(09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition

CEP350 BPTF ATRX MBD1 RSF1 ANKRD11 EIF5B DYNC2I1 EEA1 USP16 NIPBL IWS1

3.41e-161997012fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell(11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition

CEP350 BPTF ATRX RSF1 ANKRD11 DYNC2I1 CHD1 USP16 UTRN NIPBL IWS1

1.56e-14198701176d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell(00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition

BPTF MIS18BP1 ATRX MBD1 RSF1 ANKRD11 EIF5B EEA1 USP16 NIPBL IWS1

1.65e-14199701119674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell(01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition

BPTF MIS18BP1 ATRX MBD1 RSF1 ANKRD11 EIF5B EEA1 USP16 NIPBL

7.19e-131997010a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

CEP350 FAM133B BPTF ATRX ZRANB2 CAST ANKRD11 CHD1 UTRN NIPBL

7.56e-13200701012f1685ce8f218433068e090c9d839cd5a1910bf
ToppCelldroplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CEP350 TUT4 ATRX SPTBN1 RSF1 CHD1 ERBIN NIPBL TOP2B

1.45e-111857097adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCellH1299-infected-SARSCoV2|infected / Cell line, Condition and Strain

CEP350 NRDE2 CWF19L2 PSIP1 ATRX RSF1 EIF5B DYNC2I1 ANKRD36C

2.54e-111977090fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell(04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition

BPTF ATRX RSF1 ANKRD11 EIF5B EEA1 USP16 NIPBL IWS1

2.78e-1119970953ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCelldroplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TUT4 ATRX SPTBN1 GRAMD2B UTRN ERBIN TOP2B HDGFL3

4.68e-101827081710eab3037a87609d21838be2d2d29c3bc36651
ToppCelldroplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CEP350 TUT4 ATRX SPTBN1 CHD1 ERBIN NIPBL TOP2B

4.68e-10182708f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCelldroplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TUT4 ATRX SPTBN1 GRAMD2B UTRN ERBIN TOP2B HDGFL3

4.68e-10182708e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CEP350 ATRX SPTBN1 CAST ANKRD11 ERBIN ESCO1 TOP2B

6.86e-1019170860c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CEP350 ATRX SPTBN1 CAST ANKRD11 ERBIN ESCO1 TOP2B

6.86e-1019170809db184cb90fe282a14474d7217068c58092c6f8
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CEP350 ATRX SPTBN1 CAST ANKRD11 ERBIN ESCO1 TOP2B

6.86e-10191708973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

CEP350 BPTF ATRX ZFYVE16 RSF1 PCNX1 CRYBG3 UTRN

7.45e-10193708abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell(1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)

BPTF CWF19L2 TUT4 ATRX SPTBN1 ZRANB2 ANKRD11 ANKRD36C

8.09e-10195708d3fa551bc6f5ee5890af1040415e61ecd5d46201
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

FAM133B BPTF CWF19L2 ATRX ZRANB2 ANKRD11 ANKRD36C UTRN

9.49e-10199708f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCellLPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

BPTF TCF4 TUT4 MAST4 ATRX SPTBN1 UTRN NIPBL

9.88e-10200708dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell(08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition

BPTF MIS18BP1 RSF1 ANKRD11 DYNC2I1 NIPBL IWS1

2.24e-09138707817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCelldroplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CEP350 ATRX P4HA1 CAST ERBIN ESCO1 TOP2B

1.21e-08176707749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

ANKRD11 PCNX1 CHD1 ANKRD36C UTRN NIPBL ITPR1

1.91e-08188707ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCelldroplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BPTF TCF4 ATRX ANKRD11 EIF5B CHD1 NIPBL

1.91e-08188707d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCellCOVID-19_Mild|World / Disease group, lineage and cell class

FAM133B TUT4 ANKRD11 CHD1 USP16 UTRN ERBIN

2.63e-081977075c33454b10023decd2f5ccda9229b6512659711e
ToppCell10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

TCF4 MIS18BP1 PSIP1 SPTBN1 NUF2 DEK TOP2B

2.73e-081987078aa4149d2c1cec73cfd654db093252ec8ec5ef68
ToppCellPBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)

FAM133B TUT4 ANKRD11 CHD1 USP16 UTRN ERBIN

2.73e-0819870744417089b62056269cac38d3134ff209c05b7007
ToppCellPBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

FAM133B TUT4 ANKRD11 CHD1 USP16 UTRN ERBIN

2.73e-0819870728ef3fc4c17dcb765537b75917f7db78baa522db
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster

BPTF TCF4 TUT4 ATRX RSF1 ANKRD36C TOP2B

2.73e-08198707de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCellCOVID-19_Moderate|World / disease group, cell group and cell class

CWF19L2 TUT4 PSIP1 ATRX SPTBN1 ZRANB2 ANKRD36C

2.82e-08199707952fac67588ad5676f5939e3c7f8bac803c27064
ToppCell(05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition

BPTF ATRX RSF1 ANKRD11 EIF5B EEA1 USP16

2.82e-08199707d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell(02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition

BPTF ATRX RSF1 ANKRD11 EEA1 USP16 NIPBL

2.82e-0819970718a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCellLPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

BPTF TCF4 TUT4 MAST4 ATRX SPTBN1 UTRN

2.92e-08200707a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

FAM133B TUT4 PCNX1 CHD1 ANKRD36C UTRN

2.96e-071717062e9a20f8980b78325c52065a9c14ab3656267c05
ToppCelldroplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CEP350 TUT4 ATRX UTRN ESCO1 TOP2B

4.85e-0718670626f1e9930adf2fe4af0819e56f69915bd8330e4a
ToppCell10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

TCF4 PSIP1 SPTBN1 ZRANB2 HNRNPC TOP2B

5.49e-07190706f623f0bdece6002b68ac2207e99408b24a2b1194
ToppCell10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

FAM133B TCF4 CHD1 UTRN TOP2B ITPR1

5.66e-0719170640813c397f533c2f4a6359a77757f736b6d9e07d
ToppCellH1299-infected|H1299 / Cell line, Condition and Strain

SRRT BPTF TCF4 ANKRD11 EIF5B ANKRD36C

5.84e-071927069cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCellCOPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class

NRDE2 DMXL2 MIS18BP1 SIPA1L1 PCNX1 EPB41L3

6.20e-071947067d682408e9a6239a4e47befc9376e760cc3d133a
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

FAM133B TCF4 TUT4 ATRX RPGR ANKRD36C

6.39e-07195706ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCell10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

TCF4 SPTBN1 ZRANB2 UTRN TOP2B ITPR1

6.39e-07195706dc84a910b6f6eb9994cd683aa4fd813a82198e5f
ToppCellCV-Moderate-6|CV / Virus stimulation, Condition and Cluster

CEP350 BPTF ATRX ANKRD11 EIF5B ITPR1

6.58e-071967067bced0cc2112697593c478fa291b8ed3941fb811
ToppCell10x3'2.3-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

TCF4 MIS18BP1 SPTBN1 NUF2 DEK TOP2B

7.19e-07199706fe3b7d540a644dfc6beea171c809b4d1ba4e188f
ToppCell10x3'2.3-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

TCF4 MIS18BP1 SPTBN1 NUF2 DEK TOP2B

7.19e-07199706cdee798e3586e4e7a15de598239090a85752ea1e
ToppCell10x3'2.3-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

TCF4 MIS18BP1 PSIP1 SPTBN1 DEK TOP2B

7.41e-0720070619a4213f180ac2d29625d140b602a93a74ab3fdd
ToppCell10x3'2.3-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

TCF4 MIS18BP1 PSIP1 SPTBN1 DEK TOP2B

7.41e-072007060fd9a8730b7dc461ddf4586899d363541e72d8ba
ToppCell10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue

SPTBN1 PCNX1 ANKRD36C UTRN ITPR1

5.70e-06162705b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCellfacs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAST4 PCLO GRAMD2B PCNX1 USP16

8.07e-06174705f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCelldroplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TUT4 GRAMD2B UTRN TOP2B HDGFL3

9.00e-061787058aef208b6351143562c87715bb11628880abce94
ToppCellCOVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type

TCF4 MAST4 RPGR UTRN HDGFL3

9.25e-061797052a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

TUT4 MAST4 SPTBN1 PCNX1 ERBIN

1.00e-05182705b427e43ee523a3ea9eca3207f3d82042f10f022a
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

TUT4 MAST4 SPTBN1 PCNX1 ERBIN

1.00e-051827051aea96ee211f7b9caef7fd385233f51be6021a73
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

TUT4 MAST4 SPTBN1 PCNX1 ERBIN

1.00e-05182705c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

TUT4 MAST4 SPTBN1 PCNX1 ERBIN

1.00e-051827054cb182ef39be2044a6ad7266f332d4177591e550
ToppCellCOVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class

TUT4 MAST4 SPTBN1 PCNX1 ERBIN

1.03e-051837057717fce227b4e02ed41baad8ae7dd2e22bd7c13e
ToppCelldroplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CEP350 ATRX SPTBN1 UTRN ESCO1

1.11e-051867050ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCellILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

FAM133B MIS18BP1 ZFYVE16 CHD1 UTRN

1.14e-051877050099def970fbc828756fbf853eca2ce77b8cd342
ToppCellPND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

BPTF ATRX SPTBN1 ANKRD11 UTRN

1.23e-05190705d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

TUT4 SPTBN1 ANKRD36C UTRN ESCO1

1.23e-0519070591ba66d4b56c59523485b17738e93f14bb00afa4
ToppCellPBMC-Control-cDC_4|Control / Compartment, Disease Groups and Clusters

MIS18BP1 ATRX ZRANB2 CRYBG3 DEK

1.30e-05192705385061d6257295bd515dea98f9bcd52374509276
ToppCellnucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SIPA1L1 ANKRD11 PCNX1 EPB41L3 UTRN

1.33e-05193705779276e775cb2492e8dd36436295a536084a6415
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

BPTF TUT4 UTRN ERBIN NIPBL

1.33e-05193705e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCelldroplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TUT4 ATRX CHD1 NIPBL TOP2B

1.36e-051947058ef0b71fef5b84cfd04973f891215333e7035d1d
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FAM133B CWF19L2 PSIP1 NUF2 DEK

1.36e-051947057a66bd7d4fc9c6db861cedd2487f241e406869d1
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FAM133B NRDE2 CWF19L2 EIF5B DEK

1.36e-0519470540c6e17e9e48d4fa6da3a0a1066c4c6565a1e096
ToppCelldroplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATRX ANKRD11 CHD1 UTRN NIPBL

1.36e-05194705e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell10x5'v1-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

TCF4 MIS18BP1 PSIP1 SPTBN1 TOP2B

1.47e-051977057290f05d0b8465637420119941bcbf2fae44a7e4
ToppCellsevere-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

FAM133B ZRANB2 ANKRD11 ANKRD36C UTRN

1.47e-0519770557ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell10x5'v1-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

TCF4 MIS18BP1 PSIP1 SPTBN1 TOP2B

1.47e-0519770531dfd9842410b5c629f39b5130233995dceb0aef
ToppCellMild|World / Condition, Lineage, Cell class and cell subclass

CEP350 TUT4 MIS18BP1 ATRX ZRANB2

1.47e-05197705476b0d0389f9fcd4614f6bb1f494281f467f6730
ToppCell10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

FAM133B TCF4 MIS18BP1 SPTBN1 TOP2B

1.51e-051987055f465cf5c7493e32d9afe9e9d05757d0a95acc33
ToppCell10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

FAM133B TCF4 MIS18BP1 SPTBN1 TOP2B

1.51e-0519870577ce3fe1ab161c0faf8987e73a64ab61294b9255
ToppCell10x5'v1-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

TCF4 MIS18BP1 PSIP1 SPTBN1 TOP2B

1.54e-05199705ea75804c34989c99aab542e6d72617ed144819b6
ToppCell10x5'v1-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

TCF4 MIS18BP1 PSIP1 SPTBN1 TOP2B

1.54e-05199705713dfd8552635645db5e0b5721c64e5c9b4aa06c
ToppCell10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

TCF4 PSIP1 NUF2 DEK TOP2B

1.54e-051997058daf945fc93169b0a4fa3ef9f4a87eedd52e314a
ToppCellcritical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CEP350 MIS18BP1 PSIP1 NUF2 HDGFL3

1.58e-05200705f39db4250ce220a3eb58edee3f7fc3671701d46f
ToppCellCOVID-19|World / Disease, condition lineage and cell class

BPTF ANKRD11 CHD1 UTRN NIPBL

1.58e-052007057dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

TCF4 SIPA1L1 RPGR ITPR1

2.74e-05110704bc1986e5a496a4d25da3445b6f252f81741619f4
ToppCell3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

FAM133B ZRANB2 PCNX1 ANKRD36C

8.48e-0514770494998bc40f5c08295cfe3bdcbe43f13b1e564b3d
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

TCF4 SIPA1L1 RPGR ITPR1

1.26e-041637046bed27d2f67a430a847da5eb47878d14b4949c45
ToppCellControl-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)

TUT4 SPTBN1 PCNX1 ERBIN

1.52e-04171704d18855b24aadea38fd1e4592f945cf15b85e05f1
ToppCellMild/Remission-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

TCF4 TUT4 RPGR UTRN

1.59e-04173704694d02c4d2dc2de4b344544f9124fec40fcf7d8f
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

TCF4 SIPA1L1 RPGR ITPR1

1.59e-04173704d56e337eae727a29cd53cfd628e1b3c0a98e1f51
ToppCellPND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DMXL2 MIS18BP1 NUF2 DEK

1.62e-0417470465147b0f8c2ccadd5685430d31081520c157536a
ToppCell356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)

CWF19L2 MAST4 PCNX1 AP3B1

1.66e-04175704f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f
ToppCellfacs-Large_Intestine-Proximal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GRAMD2B EPB41L3 AP3B1 ERBIN

1.70e-041767041dd54bfaa58541de51e5a8328651d390833bd480
ToppCellfacs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAST4 PCLO GRAMD2B PCNX1

1.77e-04178704fcbbcc44271515de1969b4732b6441c012693d5f
ToppCelldroplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATRX ANKRD11 CHD1 UTRN

1.77e-0417870401dafd19de04eff459253eaa9a35debf8f3deedf
ToppCellCOVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

TCF4 P4HA1 SPTBN1 RPGR

1.81e-04179704754f69bac7a1d5137f5141f6193285ccbfe361cb
ToppCellCOVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class

TUT4 MAST4 PCNX1 ERBIN

1.93e-04182704877b6e611626628e709568747512f2827ebb2795
ToppCelldroplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TUT4 CHD1 ESCO1 TOP2B

1.93e-04182704eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCelldroplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TUT4 CHD1 ESCO1 TOP2B

1.97e-0418370428cbf909424f3be4491d49832f0aca0386560814
ToppCelldroplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TUT4 CHD1 ESCO1 TOP2B

1.97e-041837043fa608aa6b119869ec3280dc388dfee57160e63a
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9

TCF4 CRYBG3 EEA1 UTRN

2.01e-0418470467164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCelldroplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DMXL2 MIS18BP1 PCLO NUF2

2.01e-0418470416aa8e88bdd51b1d132d5cf33c29963b384a8bae
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

DMXL2 ZFYVE16 P4HA1 EPB41L3

2.01e-04184704e343dd7777a29048e3f12a939f7f782b8b7b4fea
ToppCellCOPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class

SIPA1L1 PCNX1 CHD1 EPB41L3

2.01e-04184704ceec41ed5636032aaf7716d1203816ea58bd39bd
ToppCelldroplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DMXL2 MIS18BP1 PCLO NUF2

2.05e-04185704b4af9ae4c358b48357cb135b740266e1652d886a
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9

CEP350 ATRX ERBIN IWS1

2.10e-0418670403db813598b67b1e08f759758a1c2023396921fa
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

CEP350 BPTF ATRX ANKRD11 UTRN

1.35e-0649435GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

CEP350 BPTF ATRX EIF5B UTRN

1.35e-0649435GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

BPTF TUT4 ATRX ANKRD11

4.47e-0550434GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1
ComputationalNeighborhood of DDX5

BPTF MBD1 CHD1 NIPBL

1.11e-0463434GNF2_DDX5
ComputationalNeighborhood of RAP1A

CEP350 SFSWAP ATRX EIF5B UTRN

2.26e-04140435MORF_RAP1A
ComputationalNeighborhood of FANCG

SRRT SFSWAP ATRX EIF5B AP3B1

5.09e-04167435MORF_FANCG
ComputationalNeighborhood of RAB10

CEP350 ZRANB2 EEA1 ERBIN IWS1

6.47e-04176435GCM_RAB10
ComputationalNeighborhood of ERCC2

SFSWAP ATRX P4HA1 EIF5B

7.64e-04104434MORF_ERCC2
ComputationalNeighborhood of RAF1

SRRT SFSWAP DEK HNRNPC

9.75e-04111434MORF_RAF1
ComputationalNeighborhood of AATF

SRRT SAFB SFSWAP DEK HNRNPC

1.40e-03209435MORF_AATF
ComputationalNeighborhood of CDC2L5

CEP350 SFSWAP ATRX UTRN

2.42e-03142434MORF_CDC2L5
ComputationalNeighborhood of RBBP6

MRPS31 BPTF USP16

2.71e-0370433GNF2_RBBP6
Drugirinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A

BPTF TCF4 MAST4 SIPA1L1 ANKRD11 ERBIN NIPBL

9.60e-071717077535_DN
DrugEtifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A

CEP350 BPTF TCF4 MIS18BP1 PCLO ANKRD11 EEA1

1.26e-061787073998_DN
DrugCinoxacin [28657-80-9]; Down 200; 15.2uM; HL60; HT_HG-U133A

CYLC1 SRRT ATRX CAST ETAA1 AP3B1 UTRN

2.08e-061927072722_DN
DrugTolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A

CEP350 CYLC1 SAFB MIS18BP1 SFSWAP SPTBN1 EEA1

2.39e-061967074844_DN
DrugGabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A

CYLC1 SAFB MIS18BP1 MBD1 ETAA1 RPGR EEA1

2.39e-061967077357_DN
DrugClorgyline

CEP350 ATRX ZFYVE16 UTRN NIPBL ESCO1

1.31e-05168706ctd:D003010
Drugirinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A

MRPS31 CEP350 BPTF CHD1 ERBIN NIPBL

2.13e-051837067498_DN
DrugApigenin [520-36-5]; Down 200; 14.8uM; PC3; HT_HG-U133A

TCF4 GRAMD2B RPGR UTRN NIPBL ITPR1

2.33e-051867064578_DN
DrugNeostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A

CEP350 BPTF SFSWAP PCLO EEA1 UTRN

2.47e-051887066735_DN
DrugCloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A

CEP350 TCF4 MIS18BP1 SFSWAP ATRX SPTBN1

2.55e-051897064271_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

BPTF KCTD3 GRAMD2B EPB41L3 ERBIN HDGFL3

2.70e-051917067503_DN
DrugProcainamide hydrochloride [614-39-1]; Down 200; 14.8uM; PC3; HT_HG-U133A

GPALPP1 MBD1 PCNX1 AP3B1 UTRN ITPR1

2.95e-051947064602_DN
DrugCefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A

CEP350 TCF4 MIS18BP1 SFSWAP ANKRD11 EEA1

3.04e-051957066159_DN
DrugThioguanosine [85-31-4]; Down 200; 12.6uM; PC3; HT_HG-U133A

MRPS31 CEP350 GPALPP1 BPTF TCF4 EEA1

3.04e-051957066643_DN
DrugSulfadiazine [68-35-9]; Up 200; 16uM; PC3; HT_HG-U133A

PCLO ETAA1 EEA1 AP3B1 UTRN HDGFL3

3.13e-051967061810_UP
DrugTolnaftate [2398-96-1]; Up 200; 13uM; PC3; HG-U133A

DMXL2 SFSWAP RSF1 EIF5B EPB41L3 HDGFL3

3.22e-051977061919_UP
DrugZimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; PC3; HG-U133A

KCTD3 EIF5B MORC2 ERBIN TOP2B HDGFL3

3.22e-051977061930_DN
DrugOfloxacin [82419-36-1]; Down 200; 11uM; PC3; HT_HG-U133A

ZNF142 SAFB MAST4 ATRX AP3B1 NIPBL

3.31e-051987067372_DN
DrugScopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; HL60; HG-U133A

MIS18BP1 SFSWAP STAU2 KCTD3 ANKRD11 EPB41L3

3.31e-051987061415_DN
DrugProcaine hydrochloride [51-05-8]; Down 200; 14.6uM; HL60; HT_HG-U133A

DMXL2 TUT4 SFSWAP SPTBN1 PCNX1 RPGR

3.31e-051987061838_DN
DrugAcemetacin [53164-05-9]; Down 200; 9.6uM; PC3; HT_HG-U133A

CYLC1 TCF4 SAFB ZFYVE16 AP3B1 ITPR1

3.40e-051997066361_DN
DrugChloroprene

PKNOX2 BPTF TCF4 CWF19L2 TUT4 ATRX SPTBN1 MBD1 KCTD3 ANKRD11 EIF5B CHD1 DEK ESCO1

5.16e-0513487014ctd:D002737
DrugThimerosal

CEP350 FSIP2 MIS18BP1 ATRX P4HA1 PCLO SPTBN1 PCNX1 EEA1 USP16 NIPBL ESCO1 IWS1

6.45e-0511997013ctd:D013849
DrugHSR-903

SPTBN1 TOP2B

1.39e-046702CID000477670
Druggeldanamycin

SRRT MIS18BP1 ATRX SPTBN1 EEA1 NIPBL ESCO1

1.43e-04371707ctd:C001277
DrugDihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; HL60; HG-U133A

TCF4 ZFYVE16 SIPA1L1 EPB41L3 HDGFL3

1.65e-041677051745_UP
DrugColchicine [64-86-8]; Up 200; 10uM; HL60; HG-U133A

SIPA1L1 MBD1 RSF1 CAST EPB41L3

1.84e-041717051598_UP
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A

BPTF SAFB SFSWAP SIPA1L1 NIPBL

2.46e-041827051891_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A

BPTF SAFB SIPA1L1 USP16 NIPBL

2.46e-041827051951_DN
Drug0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A

CEP350 BPTF ZNF142 SFSWAP MORC2

2.46e-041827053630_DN
DrugRolitetracycline [751-97-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A

CYLC1 DMXL2 MBD1 ETAA1 PCNX1

2.65e-041857053369_DN
DrugMepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A

CEP350 TCF4 MIS18BP1 PCNX1 EEA1

2.92e-041897054304_DN
DrugChlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A

TCF4 MIS18BP1 SPTBN1 UTRN ITPR1

2.92e-041897053788_DN
DrugResveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A

CYLC1 TCF4 MIS18BP1 ATRX HDGFL3

2.92e-041897055084_DN
DrugPempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A

CEP350 TCF4 SFSWAP PCNX1 EEA1

2.99e-041907054307_DN
DrugPromazine hydrochloride [53-60-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A

SRRT MAST4 ATRX SPTBN1 MBD1

2.99e-041907053833_DN
DrugFlunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A

TCF4 MIS18BP1 ATRX PCNX1 EEA1

3.07e-041917054303_DN
DrugHomatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A

CEP350 MIS18BP1 PCLO MBD1 UTRN

3.14e-041927055058_DN
DrugAzacyclonol [115-46-8]; Down 200; 15uM; PC3; HG-U133A

KCTD3 EIF5B EPB41L3 TOP2B HDGFL3

3.14e-041927051937_DN
DrugMeclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A

GPALPP1 MIS18BP1 MAST4 SFSWAP PCLO

3.14e-041927054268_DN
DrugBerberine chloride [633-65-8]; Down 200; 10.8uM; HL60; HG-U133A

ZFYVE16 MBD1 CAST ANKRD11 TOP2B

3.14e-041927051778_DN
DrugAntimycin A [1397-94-0]; Down 200; 7.2uM; PC3; HT_HG-U133A

BPTF TCF4 ETAA1 AP3B1 NIPBL

3.22e-041937052098_DN
DrugNimodipine [66085-59-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A

GPALPP1 DMXL2 PCLO PENK MORC2

3.22e-041937055421_UP
DrugGlycocholic acid [475-31-0]; Down 200; 8.6uM; PC3; HT_HG-U133A

SRRT TCF4 SAFB SPTBN1 UTRN

3.22e-041937056716_DN
DrugOmeprazole [73590-58-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A

SRRT MAST4 ATRX PCNX1 ITPR1

3.22e-041937052828_DN
DrugIsoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; MCF7; HT_HG-U133A

CEP350 SRRT EEA1 NIPBL ITPR1

3.30e-041947052824_DN
DrugGabazine [105538-73-6]; Up 200; 10.8uM; HL60; HT_HG-U133A

SRRT DMXL2 ETAA1 PCNX1 MORC2

3.30e-041947051316_UP
DrugHesperidin [520-26-3]; Up 200; 6.6uM; HL60; HT_HG-U133A

CYLC1 SIPA1L1 ETAA1 UTRN HDGFL3

3.30e-041947051294_UP
DrugCapsaicin [404-86-4]; Down 200; 13uM; PC3; HT_HG-U133A

SRRT TCF4 MBD1 PCNX1 UTRN

3.30e-041947054612_DN
DrugFamprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A

TCF4 ATRX RSF1 EIF5B PCNX1

3.30e-041947054309_DN
DrugMenadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A

BPTF ETAA1 PCNX1 EPB41L3 NIPBL

3.30e-041947054662_DN
DrugBenfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A

TCF4 MIS18BP1 SFSWAP PCNX1 EEA1

3.30e-041947054312_DN
DrugNafronyl oxalate [3200-06-4]; Up 200; 8.4uM; HL60; HT_HG-U133A

PKNOX2 SRRT SPTBN1 UTRN HDGFL3

3.30e-041947051267_UP
Drug6-mercaptopurine monohydrate; Down 200; 10uM; PC3; HG-U133A

DMXL2 MAST4 STAU2 CHD1 NIPBL

3.37e-04195705667_DN
DrugPHA-00767505E [723337-45-9]; Up 200; 10uM; PC3; HT_HG-U133A

SPTBN1 PCNX1 EEA1 AP3B1 NIPBL

3.37e-041957056545_UP
Drugcolchicine; Down 200; 1uM; SKMEL5; HG-U133A

MRPS31 SPTBN1 EIF5B AP3B1 NIPBL

3.37e-04195705630_DN
DrugAtropine-N-oxide hydrochloride [4574-60-1]; Up 200; 11.8uM; HL60; HG-U133A

GPALPP1 TCF4 RSF1 EIF5B EPB41L3

3.37e-041957051370_UP
DrugLactobionic acid [96-82-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A

SIPA1L1 ETAA1 AP3B1 UTRN ITPR1

3.37e-041957053246_UP
DrugAmodiaquin dihydrochloride dihydrate [6398-98-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A

TUT4 SIPA1L1 ETAA1 RPGR UTRN

3.37e-041957056224_UP
DrugPrednisone [53-03-2]; Up 200; 11.2uM; HL60; HG-U133A

TCF4 DMXL2 KCTD3 NIPBL ITPR1

3.45e-041967051978_UP
DrugIndomethacin [53-86-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A

DMXL2 SPTBN1 MBD1 PCNX1 ITPR1

3.45e-041967057409_UP
DrugEdrophonium chloride [116-38-1]; Down 200; 19.8uM; PC3; HG-U133A

CEP350 RSF1 EPB41L3 NIPBL TOP2B

3.45e-041967051936_DN
Drugalpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA

CYLC1 ATRX PCNX1 UTRN ITPR1

3.45e-04196705990_UP
DrugDisopyramide [3737-09-5]; Up 200; 11.8uM; PC3; HT_HG-U133A

MIS18BP1 ATRX EIF5B DYNC2I1 EEA1

3.45e-041967057276_UP
DrugOfloxacin [82419-36-1]; Down 200; 11uM; PC3; HT_HG-U133A

SRRT TUT4 PCNX1 UTRN ITPR1

3.45e-041967053673_DN
DrugLY 294002; Up 200; 10uM; MCF7; HT_HG-U133A

SPTBN1 MBD1 PCNX1 UTRN ITPR1

3.45e-041967055236_UP
DrugHymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A

PKNOX2 DMXL2 SIPA1L1 ETAA1 PCNX1

3.45e-041967053383_DN
DrugTriprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A

GPALPP1 MAST4 SPTBN1 MBD1 PCNX1

3.45e-041967057408_UP
DrugBuflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A

SRRT MBD1 EEA1 AP3B1 NIPBL

3.45e-041967054840_DN
DrugPentoxifylline [6493-05-6]; Down 200; 14.4uM; HL60; HG-U133A

CEP350 KCTD3 RSF1 EIF5B NIPBL

3.45e-041967051444_DN
DrugPilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A

ATRX SPTBN1 ETAA1 EEA1 UTRN

3.54e-041977055341_DN
DrugGuanabenz acetate [23256-50-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A

PKNOX2 SRRT PCLO MBD1 ITPR1

3.54e-041977055703_UP
DrugIsoxicam [34552-84-6]; Up 200; 12uM; MCF7; HT_HG-U133A

CEP350 SRRT ETAA1 PCNX1 ITPR1

3.54e-041977051698_UP
DrugPropantheline bromide [50-34-0]; Down 200; 9uM; PC3; HT_HG-U133A

SRRT MAST4 SPTBN1 PCNX1 UTRN

3.54e-041977054214_DN
DrugNaproxen [22204-53-1]; Down 200; 17.4uM; PC3; HT_HG-U133A

TCF4 SAFB SFSWAP ETAA1 RPGR

3.54e-041977051828_DN
DrugHemicholinium bromide [312-45-8]; Down 200; 7uM; MCF7; HT_HG-U133A

ATRX SPTBN1 ETAA1 EEA1 HDGFL3

3.54e-041977053216_DN
DrugAllantoin [97-59-6]; Up 200; 25.2uM; PC3; HT_HG-U133A

TCF4 ZFYVE16 PCLO SPTBN1 NIPBL

3.54e-041977051800_UP
DrugMycophenolic acid [24280-93-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A

MAST4 SIPA1L1 MBD1 ANKRD11 RPGR

3.54e-041977054137_DN
DrugMedrysone [2668-66-8]; Down 200; 11.6uM; PC3; HT_HG-U133A

CEP350 TCF4 SFSWAP ATRX PCLO

3.54e-041977054266_DN
DrugHymecromone [90-33-5]; Up 200; 22.8uM; MCF7; HT_HG-U133A

PKNOX2 TNN TRPC4 PCNX1 ITPR1

3.54e-041977055684_UP
DrugGold

ZFYVE16 STAU2 ZRANB2 EIF5B EEA1 USP16 NIPBL

3.61e-04432707ctd:D006046
DrugTrimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; HL60; HG-U133A

ZNF142 SAFB TUT4 MBD1 MORC2

3.62e-041987052002_DN
DrugAzacyclonol [115-46-8]; Down 200; 15uM; HL60; HG-U133A

ZNF142 MIS18BP1 SFSWAP MBD1 NIPBL

3.62e-041987052020_DN
DrugTroleandomycin [2751-09-9]; Down 200; 5uM; PC3; HG-U133A

CEP350 PSIP1 STAU2 EIF5B NIPBL

3.62e-041987051885_DN
DrugSulfathiazole [72-14-0]; Down 200; 15.6uM; HL60; HG-U133A

SAFB SFSWAP STAU2 EPB41L3 ERBIN

3.62e-041987051963_DN
Drug2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; MCF7; HT_HG-U133A

DMXL2 PENK PCNX1 MORC2 ITPR1

3.62e-041987055422_UP
DrugPhentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; HL60; HT_HG-U133A

ZNF142 CAST PCNX1 UTRN NIPBL

3.62e-041987052362_DN
Drug5255229; Down 200; 13uM; MCF7; HT_HG-U133A_EA

CEP350 ZNF142 PCNX1 AP3B1 ITPR1

3.62e-04198705949_DN
DrugBezafibrate [41859-67-0]; Down 200; 11uM; MCF7; HT_HG-U133A

CYLC1 SRRT SAFB MBD1 ETAA1

3.62e-041987054999_DN
DrugCorynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A

DMXL2 ZNF142 TUT4 MAST4 ETAA1

3.62e-041987052786_DN
DrugCarbetapentane citrate [23142-01-0]; Down 200; 7.6uM; MCF7; HT_HG-U133A

CYLC1 SFSWAP ATRX ETAA1 NIPBL

3.62e-041987052623_DN
DrugNalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A

CYLC1 MAST4 SPTBN1 MBD1 DYNC2I1

3.62e-041987057177_DN
DrugNilutamide [63612-50-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A

SRRT SPTBN1 ETAA1 EEA1 ITPR1

3.62e-041987056481_DN
DrugAsiaticoside [16830-15-2]; Down 200; 4.2uM; PC3; HT_HG-U133A

TCF4 EIF5B RPGR EEA1 ITPR1

3.62e-041987057244_DN
DrugOxytetracycline dihydrate [6153-64-6]; Down 200; 8uM; HL60; HG-U133A

ZNF142 SAFB SFSWAP UTRN NIPBL

3.62e-041987051553_DN
DrugRiluzole hydrochloride; Down 200; 14.8uM; HL60; HT_HG-U133A

CYLC1 SRRT ZNF142 ATRX EEA1

3.62e-041987052334_DN
DrugAmyleine hydrochloride [532-59-2]; Up 200; 14.8uM; HL60; HG-U133A

TCF4 DMXL2 KCTD3 DYNC2I1 ITPR1

3.70e-041997051991_UP
DrugAminophylline [317-34-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A

PKNOX2 TCF4 SPTBN1 PENK ITPR1

3.70e-041997055395_UP
DrugMoxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; PC3; HT_HG-U133A

ZFYVE16 PCNX1 RPGR EEA1 MORC2

3.70e-041997057255_DN
DrugPindolol [13523-86-9]; Down 200; 16.2uM; PC3; HT_HG-U133A

PCLO PCNX1 AP3B1 UTRN HDGFL3

3.79e-042007052075_DN
Diseasecastration-resistant prostate carcinoma (is_implicated_in)

CHD1 NUF2

1.61e-053692DOID:0080909 (is_implicated_in)
Diseaseurate measurement, bone density

FSIP2 MAST4 ANKRD11 CPSF2 UTRN ERBIN HNRNPC ITPR1

9.73e-05619698EFO_0003923, EFO_0004531
Diseasealcohol dependence

PKNOX2 TNN CAST PCNX1

9.04e-04183694MONDO_0007079
DiseaseNeurodevelopmental Disorders

TCF4 ANKRD11 ITPR1

1.37e-0393693C1535926
Diseasegrip strength measurement

BPTF SEC16B TCF4 KCTD3 ITPR1

1.38e-03350695EFO_0006941
DiseaseC-reactive protein measurement

BPTF SEC16B TCF4 CWF19L2 DMXL2 CAST HNRNPC TOP2B ITPR1

1.93e-031206699EFO_0004458
Diseaseunipolar depression, irritable bowel syndrome

TCF4 PCLO

1.96e-0328692EFO_0000555, EFO_0003761
DiseaseQRS-T angle

SIPA1L1 SPTBN1 PCNX1

1.99e-03106693EFO_0020097
Diseasecardiovascular age measurement

SIPA1L1 SPTBN1

2.10e-0329692EFO_0803380

Protein segments in the cluster

PeptideGeneStartEntry
NNKKDDTKETDSLSD

ERBIN

631

Q96RT1
ELFSTEKKDKNDSER

ANKRD11

1421

Q6UB99
KQSSFKDDQDKTEKD

CRYBG3

141

Q68DQ2
AKKLEQSKEADIDSS

CPSF2

406

Q9P2I0
TDAREKDKQSDQKAS

DMXL2

2001

Q8TDJ6
TEKDKNETENDSKDA

BPTF

576

Q12830
KDQDVKELLDSDSDK

BPTF

1121

Q12830
EKSDEDDDKLSESKS

CHD1

1361

O14646
EKENEKSKTSDSSND

AP3B1

756

O00203
KKNEEKDLFGSDSES

IWS1

451

Q96ST2
KKDAEEDDSLANSSD

PENK

141

P01210
DEKDSFSNITREKKD

ANKRD36C

796

Q5JPF3
DKSEEEQSSSSVKKD

HNRNPC

231

P07910
LQDSSKKEADSKSAV

LSM11

231

P83369
EKENNKSFQSDDSSL

MIS18BP1

166

Q6P0N0
DDFKDKLNLKESDDS

IL31RA

571

Q8NI17
NTSDLGNKKKDDEVD

ITPR1

1886

Q14643
ENLQDTKSSEDKKLD

TCF4

521

P15884
DDKKDIKSITSNNDD

TCF4

536

P15884
SKEKSNSFSDKGEER

DYNC2I1

241

Q8WVS4
SSTNKNISAKEKEEE

FSIP2

5736

Q5CZC0
EDKEENKDDSASKLA

MBD1

546

Q9UIS9
EAQASTLADEKSEKK

PCLO

1421

Q9Y6V0
AENKEEKSDKSAVSV

PCNX1

511

Q96RV3
SDESELKKLKTEENS

NUF2

326

Q9BZD4
QSKLEDAEKAASTKE

CWF19L2

266

Q2TBE0
NAKKSSDAESEDSKD

CYLC1

291

P35663
SDAESEDSKDAKKDS

CYLC1

296

P35663
TDNKKSVKNDEESTD

CYLC1

431

P35663
SSEKDSNAEEDSNKK

NIPBL

1506

Q6KC79
LKSESSDESDTNKKL

NRDE2

61

Q9H7Z3
EDDKDCKEEENKSSS

HDGFL3

166

Q9Y3E1
SESLKQSSKEEEEKN

ETAA1

876

Q9NY74
VKEEKKDSNELSDSA

MORC2

766

Q9Y6X9
KDVNKSASDDQSDQK

P4HA1

256

P13674
SDSLKNSKSEFEKEN

EEA1

866

Q15075
EKFLKKDQSDETSED

ATRX

966

P46100
KDQSDETSEDDKKQS

ATRX

971

P46100
SDAEESSEDNKKKKQ

ATRX

1156

P46100
ALEDKDTASNENKEK

CCDC125

431

Q86Z20
SSSSDSEDEDKKQGK

FAM133B

116

Q5BKY9
LSDESSSDEDEKKNK

DEK

226

P35659
SSDEDEKKNKEESSD

DEK

231

P35659
ETQEARKSSSKKDEE

GPALPP1

236

Q8IXQ4
SKLDSHSDDDTKDNK

CEP350

1801

Q5VT06
SQSDKDLDDALDKLS

CAST

561

P20810
NSAEEKEDSVDKTKS

MAST4

921

O15021
TKKSDDKNSETEIQD

ESCO1

16

Q5FWF5
ASLASDKNDCKTESK

GRAMD2B

76

Q96HH9
KNSEDDELAKESKRS

RSF1

1256

Q96T23
SESKKRSSEDENENK

KCTD3

736

Q9Y597
DLTSLLDNEDKKSKN

PKNOX2

276

Q96KN3
QLEDDKLSQKSSSSK

EPB41L3

81

Q9Y2J2
TNDDSSAETIEKKEK

RPGR

891

Q92834
ESQDSEKENTKKDLL

MRPS31

86

Q92665
LDNSKASKKINSDSE

UTRN

601

P46939
KKKSGVSSDNEDDDD

SFSWAP

276

Q12872
AAKKEESETANKNDS

TOP2B

31

Q02880
ESETANKNDSSKKLS

TOP2B

36

Q02880
KNKSEDSTKDDIDLD

EIF5B

6

O60841
EESQNASDKLKKFTE

SIPA1L1

1781

O43166
DSDGKKEKSSNSDRS

SAFB

496

Q15424
DISVETEDNKEKKSA

SPTBN1

161

Q01082
ENDSSNDDKTKKSEG

SRRT

316

Q9BXP5
DTNSDSDDDKKRVKA

NKAPL

211

Q5M9Q1
SNEDSKDNHEASTKK

PSIP1

496

O75475
DSESAEDQTKAAEQK

TIGD2

446

Q4W5G0
DKNLKKTVEDEDQDS

USP16

401

Q9Y5T5
KDVDDDKDANKSEIS

STAU2

196

Q9NUL3
EKATDEEAKAESQKA

SMTNL1

191

A8MU46
ESKKADTKAQTDIDS

TNN

696

Q9UQP3
KEDEKESSDEADKNS

SEC16B

876

Q96JE7
DASEEEDSNKKKSNR

ZRANB2

186

O95218
ENVEKEEKSDTQKDS

ZNF142

121

P52746
EEKSDTQKDSQKAVD

ZNF142

126

P52746
SDDLSKMKNDESNKE

TUT4

236

Q5TAX3
DSDEKSDSEGNSKDK

TRPC4

776

Q9UBN4
SAQEDSKSLDLKDND

ZFYVE16

341

Q7Z3T8
IQDKNEKDDSQKDTS

ZRANB3

661

Q5FWF4